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MULTIDISCIPLINARY AND MULTIOBJECTIVE DESIGN OPTIMISATION OF
CORONARY STENTS
by Sanjay Pant
Coronary stents are tubular type scaﬀolds that are deployed, using an inﬂatable balloon on a
catheter, most commonly to recover the lumen size of narrowed (diseased) arterial segments.
Even though numerous stent designs, of varying geometrical and material complexity, are used
in clinical practice today, the adverse biological responses post-stenting are not completely
eliminated. In-stent restenosis (IR), reduction in lumen size due to neointima formation
within 12 months of procedure, and stent thrombosis (ST), formation of a blood clot inside a
stented vessel, are the two most common adverse responses to stents. Such adverse responses
are multifactorial and their causes are not completely understood. However, the geometric
design of a stent, which is a common diﬀerentiating factor between the numerous commer-
cially available stents, is known to be a key factor inﬂuencing adverse responses. In light of
the above, this thesis exploits stent geometry parameterisation in both constrained and mul-
tiobjective optimisation. Gaussian process surrogate modelling is used to cost eﬀectively (a)
understand the inﬂuence of stent geometry parameters on metrics indicating adverse response,
and (b) obtain families of stent designs which are potentially more resistant to such responses.
Various computational models are developed to evaluate the eﬃcay of a stent in terms of the
factors inﬂuencing the adverse responses. In particular, two ﬁnite element analysis (FEA)
models and two computational ﬂuid dynamics (CFD) models are developed. The FEA mod-
els are used to simulate the balloon-expansion of stents in a representative coronary artery
and bending of stents on application of bending moments. On the other hand, the CFD
models simulate haemodynamic ﬂow in the stented artery and the associated drug-release
into the tissue. The expansion FEA models are validated against manufacturer provided
pressure-diameter relationship and the ﬂexibility FEA models are validated against the nu-
merical studies found in literature. The numerical models are then used to extract metrics
which are related to the adverse responses. Six metrics are formulated: (i) acute recoil, which
measures the radial strength of the stent; (ii) volume average stress, which measures potential
arterial injury caused by the stenting procedure; (iii) haemodynamic low and reverse index,
which measures the haemodynamic alteration relevant to IR; (iv) volume average drug, which
measures the amount of anti-proliferative drug delivered into the tissue; (v) drug deviation,
which measures the uniformity of drug-distribution in the tissue; and (vi) ﬂexibility metric,
which measures the deliverability of the stent. These metrics are then used to compare the
performance of diﬀerent geometric stent designs. Two parameterisation techniques – one for
a generic ring and link topology of stents, and one for the commercial CYPHER (Cordis
corporation, Johnson & Johnson company) – are proposed to study the eﬀect of geometrical
variation in stent design on the formulated metrics of eﬃcacy. These techniques are thencombined with surrogate modelling to perform stent design optimisation studies and study
the eﬀect of stent geometry on the evaluation metrics. Finally, three paradigms to choose op-
timal stent designs from a set of non-dominated solutions, in terms of the evaluation metrics,
are proposed, and optimal designs under such paradigms are identiﬁed.
The last part of this thesis concerns surrogate assisted optimisation, and is not speciﬁc to
the problem of stent design. Here, the use of analytically available gradient information
in widely used Kriging predictors is explored. A search algorithm to locate all stationary
points of a Krig, using a combination of an iterative sequence of the Krig derivative and a
low-discrepancy sequence is proposed.Contents
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Aims & objectives
Coronary stents are tubular, often mesh-like, structures which are deployed in diseased
(stenosed) artery segments to provide a scaﬀolding feature that compresses atheromatus
plaque, hence restoring luminal area and maintaining vessel patency. Despite the widespread
clinical use of stents in cardiovascular intervention, the presence of such devices can cause
adverse responses leading to fatality or to the need for further treatment. The most common
unwanted responses of inﬂammation, in-stent restenosis and thrombosis, are multifactorial.
In-stent restenosis is caused by a cascade of events triggered by vessel injury during the bal-
loon angioplasty procedure whereas late thrombosis (usually associated with drug eluting
stents) typically occurs as a result of incomplete healing whereby inhibition of intimal pro-
liferation results in exposed parts of the stent providing ideal sites for thrombogenesis. Both
patient-speciﬁc factors, such as the geometry and morphology of the disease, combine with
procedural factors, such as the size, shape, material and other design properties of the stent,
to induce such responses.
This thesis aims to evaluate the eﬀect of stent design parameters on the factors that
determine the severity of the aforementioned adverse biological responses, primarily in-stent
restenosis. Using such evaluations, design optimisation studies are conducted to obtain a
potentially optimum family of stent designs that are more resistant to the adverse responses.
1.1 Aims
Currently, an “ideal stent” – that recovers arterial shape with no adverse response – does not
exist, even though, as a multi-billion dollar industry, stent design has witnessed a fairly rapid
evolution from bare metal stents of increasing complexity, through shape memory alloy stents,
polymer coated, drug eluting stents to biodegradable (or bioresorbable or bioabsorbable)
stents made from polymers or corrodible metals. In recent years, drug eluting stents, which
elute an anti-proliferative drug to suppress smooth muscle cell proliferation, have witnessed
a major increase in popularity following early trials and approvals in 2002-2003, largely due
to their eﬀectiveness in reducing in-stent restenosis. However, more recently, late thrombosis
has been identiﬁed following the discontinuation of anti-platelet therapy. Increasing concerns
over late thrombosis with drug eluting stents has led to a signiﬁcant return to the use of bare
metal stents and to further impetus in the quest for improved alternatives.
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The coupling between arterial injury, which triggers the adverse responses, blood ﬂow,
which leads to diﬀerential shear stress distribution on the artery wall, and the distribution
of an anti-proliferative drug in the arterial tissue, all three as a function of stent geometry,
constitute a complex multi-objective problem that is poorly understood. Thus, this thesis
aims to determine how, for typical stents or a new contemplated design, geometric variation
aﬀects arterial injury, blood ﬂow, and drug distribution. Moreover, ﬂexibility of a stent, which
is extremely important for deliverability, is also a function of stent-geometry. Once a given
stent can be evaluated for the physical behaviour during and post implantation, measures
relating to the eﬃcacy of the stent in arresting in-stent restenosis and deliverability can be
extracted. These measures can then be fed back to the geometrical design of the stent to
improve stent performance. With this background, the aims of this thesis are
• to assess the performance, i.e. deliverability and resistance to in-stent restenosis, of
coronary stents in relation to variations in geometric design;
• to use this assessment in order to ﬁnd a family of stent designs that minimise the adverse
responses and maximise deliverability.
The ﬁnal part of this thesis deals with the development of an optimisation algorithm, the aim
of which is
• to evaluate if the analytically available derivative information for the widely used Krig-
ing predictor, can be used for eﬀective search of the surrogate model.
1.2 Objectives
The measurable objectives of this thesis in relation to the aims outlined above are
1. to develop a computational ﬂuid dynamics model in order to evaluate ﬂow features in
a stented coronary artery;
2. to formulate measures relating to in-stent restenosis from the above model so that stents
can be compared on their haemodynamic performance;
3. to develop a ﬁnite element analysis model in order to evaluate the process of balloon-
expansion of coronary stents;
4. to formulate measures relating to radial strength of a stent and arterial injury caused
by the procedure from the above model, which are shown to be related to in-stent
restenosis;
5. to develop a computational ﬂuid dynamics model in order to evaluate the drug-distribution
achieved by a stent in a stented coronary artery;
6. to formulate measures relating both the amount of drug delivered and uniformity of
drug-distribution from the above model, which are both relevant to arresting in-stent
restenosis;
7. to develop a ﬁnite element analysis model in order to evaluate ﬂexibility of stents on
application of bending loads;1.3. Thesis overview 3
8. to formulate a measure of ﬂexibility of a stent from the above model;
9. to construct surrogate models for each of the above extracted measures of performance;
10. to study trends in the measures of performance by variations in stent geometry with
the aid of surrogate models;
11. to propose a technique to parameterise stent geometrical design;
12. to conduct design optimisation studies – both constrained and multi-objective – to
demonstrate design improvement in coronary stents.
All the components of the above mentioned objectives can be seen in Figure 1.1, where the
optimisation methodology is depicted. In this ﬁgure, the boxes inside the dashed boundary
represent the engineering analyses part of the objectives. The ‘simulations’ columns show
the computational models that are developed and the ‘physical quantity measured’ columns
show the corresponding attribute which is related to deliverability for ﬂexibility and resistance
to in-stent restenosis for all other quantities. The boxes in the non-dashed part show the
optimisation loop. The loop starts with a parametric representation of the stent geometry,
such that diﬀerent values of the parameters result in diﬀerent stent geometries. The design
search space is deﬁned by setting up appropriate bounds on such parameters. This design
space is then sampled at a number of points, deﬁned by a sampling plan. For each point in the
sampling plan, engineering analysis is performed to evaluate the physical response. Surrogate
models are constructed for each of the measured attributes, and a search of these surrogates
is made. The results of the search are used to add more points for surrogate improvement
using an inﬁll criterion. The analyses for these added points is conducted and the results are
used to update the surrogate. The resulting surrogates are searched again and this process
is repeated until a satisfactory surrogate is constructed or the required design improvement
has been obtained or the available computational budget has been exhausted.
As mentioned in section 1.1, the last part of this thesis concerns how the analytically
available gradient information of a Kriging predictor (surrogate model) can be used for an
eﬀective search of the Krig. For this part of the thesis, the objectives are
1. to derive the equations for the derivative of a Kriging predictor;
2. to formulate an iterative sequence which can search all stationary points of a Krig;
3. to formulate an optimisation algorithm which combines the above iterative sequence
with a low-discrepancy sequence for an eﬀective search of the Krig.
1.3 Thesis overview
In this section an overview of the thesis is presented. This overview is divided into the
contents of each chapter as follows:4 Chapter 1. Aims & objectives
Figure 1.1: Optimisation methodology
1.3.1 Chapter 2
Chapter 2 introduces coronary artery disease. Anatomy and histology of the coronary artery
is presented, and the available treatments for coronary artery disease are outlined. Thereafter,
the two main adverse responses of coronary stenting: in-stent restenosis and thrombosis, are
introduced. Finally, a classiﬁcation of the variety of coronary stents available today are
presented, and computer modelling approaches to create stent geometry are outlined.
1.3.2 Chapter 3
Chapter 3 presents an introduction to surrogate modelling and optimisation. For the former,
the equations for a Gaussian process predictor are explained and for the latter, an overview
of constrained, unconstrained, single objective, and multiobjective optimisation methods –
both classical and evolutionary – is presented.
1.3.3 Chapter 4
In Chapter 4 haemodynamic evaluation of stents is presented. Pulsatile computational ﬂuid
dynamics (CFD) simulations are performed over ﬁve diﬀerent coronary stents. Based on the
results obtained, a numerical index to quantify the haemodynamic ﬂow features that inﬂuence
in-stent restenosis is formulated.1.3. Thesis overview 5
1.3.4 Chapter 5
Chapter 5 presents a model to simulate balloon expansion of a stent in a representative
diseased artery using ﬁnite element analysis (FEA). These models are validated against the
manufacturer provided experimental pressure-diameter relationship during the expansion of
the CYPHER stent, Cordis corporation, Johnson & Johnson company. Using the results of
the FEA analysis, arterial injury is quantiﬁed in a numerical index, and recoil is measured to
evaluate the radial strength of the stent.
1.3.5 Chapter 6
Chapter 6 presents a ﬁnite element model to measure the ﬂexibility of a stent, and proposes
a numerical index to quantify ﬂexibility in a numeric quantity which can be used to compare
stents based on deliverability. The FEA model used in this chapter is validated against the
numerical studies found in literature. In particular, a comparison of the moment-curvature
plot for the CYPHER stent is made against the model of De Beule [11].
1.3.6 Chapter 7
Chapter 7 presents a constrained optimisation study. A parameterisation technique to create
generic stent designs is proposed. A ﬁnite element model to evaluate drug-distribution is
described. This model, combined with the analyses of chapters 5 and 6, and the proposed
parameterisation, is used in a constrained optimisation study to obtain design improvement
from the baseline geometry.
1.3.7 Chapter 8
Chapter 8 uses the expanded geometry obtained from Chapter 5. In this expanded geometry,
ﬁrst a haemodynamic analysis is performed (using the model developed in Chapter 4), and
then a drug release simulation is performed. Unlike the drug release model of chapter 7,
the model used in this chapter includes haemodynamic ﬂow in the lumen. This chapter also
proposes numerical indices to measure both the quantity of the drug transported to the tissue,
and the uniformity of the resulting distribution.
1.3.8 Chapter 9
This chapter brings together the contents of chapters 4, 5, 6, and 8 in a multiobjective opti-
misation study for the CYPHER stent. A three parameter technique to represent CYPHER
like stents is proposed and from the results of surrogate assisted multiobjective optimisation
results, several conﬂicts between various pairs of desired attributes are shown. Features in
the geometric design of stents which eﬀect each of the measurable attributes are also identi-
ﬁed. Finally, three paradigms to choose optimal stent designs from a set of non-dominated
solutions are presented, and optimal stents under such paradigms are identiﬁed.
1.3.9 Chapter 10
Chapter 10 presents the development of a new optimisation algorithm for eﬀective search of
a Kriging predictor. The chapter presents how iterative sequences can be formed using the
analytically available derivative information for the Kriging predictor, to locate stationary6 Chapter 1. Aims & objectives
points. Such a sequence is combined with the space-ﬁlling properties of quasi-random se-
quences to propose the Krige-Newton-Raphson-Sobol (KNRS) algorithm for both global and
multimodal optimisation. Finally, the performance of this algorithm is compared with (i)
a standard genetic algorithm and a dynamic hill climbing algorithm for global optimisation
on 10 test-functions, and (ii) a ﬁtness sharing genetic algorithm and a dynamic hill climbing
algorithm for multimodal optimisation on ﬁve test functions.
1.3.10 Chapter 11
Chapter 11 concludes the thesis with a list of contributions made to (i) the areas coronary
stent design, analysis, and optimisation, and (ii) the area of surrogate assisted search and
optimisation. Finally, recommendations for further work in the aforementioned areas are
made.Chapter 2
Introduction to coronary artery
disease and stents
2.1 Introduction
Coronary artery disease (CAD), also known as atherosclerotic heart disease, is a condition
caused by the accumulation of lipids and ﬁbrous tissue (collectively referred as atherosclerotic
plaque) on the inner walls of a coronary artery [4]. This accumulation leads to narrowing
of the arteries, thereby resulting in reduced blood ﬂow to the downstream heart muscles
(myocardium), and can consequently result in chest pain (angina pectoris) or heart attack
(myocardial infraction).
CAD is a leading cause of death in western countries. According to the British Heart
Foundation [21], in 2008, CAD was the cause of 88,000 deaths in the UK (one in ﬁve male
and one in eight female deaths). Similarly, according to the American Heart Association
[22], CAD caused 425,425 deaths in the United States of America, in 2006. Even though
the treatment of CAD has evolved signiﬁcantly in the past two decades, a treatment with no
adverse eﬀects does not yet exist. This chapter has the following aims:
1. to introduce CAD and its available treatments,
2. to present the adverse issues associated with the most common treatment (coronary
stenting) for CAD,
3. to present a survey of coronary stent designs, outline the properties that are desirable
in an ideal stent, and introduce the basic stent design problem, and
4. to present computer approaches for modelling the geometry of coronary stents.
2.2 CAD and its treatments
2.2.1 Circulation in the heart: anatomical features
Coronary circulation refers to the circulation that supplies oxygen-rich blood and nutrients
to the myocardium, the muscle tissue of the heart. The vessels that supply blood to the
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myocardium are called coronary arteries and can, in general, be classiﬁed as one of the
following –
• Left Coronary Artery (LCA)
• Right Coronary Artery (RCA)
Figure 2.1: Coronary circulation: Left and Right Coro-
nary Arteries [1]
Figure 2.1 shows the two coronary
arteries, both beginning at the root
of the aorta (LCA and RCA origi-
nating from the left and right aor-
tic sinus, respectively) and travel-
ling down forming a complex tree
structure with numerous bifurca-
tions. Shortly after its origina-
tion the LCA divides into two main
branches: the anterior interventric-
ular branch (also known as the left
anterior descending (LAD) artery)
and the circumﬂex branch. Simi-
larly, the RCA divides into the right marginal artery and, in approximately 67% cases, into
the posterior interventricular branch [1].
2.2.2 Coronary artery disease
Figure 2.2: An illustration of plaque
deposition inside a coronary artery [2]
Coronary artery disease refers to the condition when
one or more branches, either the main branch or sub-
sequent bifurcations, of the LCA and/or the RCA be-
come narrowed (or get blocked) by gradual deposition
of plaque. The deposition of plaque gradually causes
the artery to harden, i.e. become less elastic. This
phenomenon is called atherosclerosis. Plaque consists
mainly of atheroma (composed of macrophage white
blood cells), cholesterol, and calcium deposits. The
deposition of plaque leads to a reduction of lumen
area. This lumen area reduction, also known as stenosis, reduces the blood supply to the
myocardium, leading to angina pectoris, chest pain, and sometimes to myocardial infraction
(MI), or heart attack. MI is generally a result of the complete blockage of an artery, usually
caused by a formation of blood clot (thrombus) over a ruptured plaque [23]. Figure 2.2 shows
a picture of a coronary artery that has narrowed down due to the deposition of plaque.
Stenosis is detected with the help of angiography, an imaging technique used to visualize
the lumen of an artery. In this process a radio-opaque agent, called contrast-agent, is in-
jected into the blood and then visualized using X-ray based techniques. Figure 2.3 shows an
angiogram where the stenosed region has been circled.2.2. CAD and its treatments 9
2.2.3 Histology of coronary artery
Figure 2.3: Angiogram of a coronary
artery: the circle shows the stenosed re-
gion [3]
The artery wall has a complex structure com-
posed of various layers with diﬀerent mechanical
properties. This makes the properties of the ar-
terial tissue highly non-linear and anisotropic. In
general, the artery wall is composed of the follow-
ing layers, proportions of which diﬀer in diﬀerent
parts of the circulation:
• The intima (inner)
• The media (middle)
• The adventitia (outer)
Figure 2.4 shows the three layers of the artery
wall structure. The inner-most layer, intima, is composed of two layers: endothelium, which
is a single layer of cells that acts as a barrier, and the internal elastic lamina that is composed
of elastic ﬁbres. The central layer, media, is the thickest layer composed of elastin, collagen,
smooth muscle cells (SMC), and ground substance (glycosaminoglycans) [24]. The outer-
most layer, adventitia, is composed largely of collagen I with admixed elastic, ﬁbroplasts,
and nerves [24]. The adventitia merges into the surrounding tissue thereby limiting the
longitudinal movement of the artery.
2.2.4 Treatments for CAD
Figure 2.4: Artery wall structure: the three layers [4]
CAD, if not severe, can be
treated by changes in lifestyle:
healthy eating, low-saturated
fat diet, regular exercise, and
not smoking [23]. However,
if the disease is severe then
either coronary artery bypass
graft (CABG) surgery, an-
gioplasty, or angioplasty with
stenting is used. The following
sections describe each of these
procedures.
2.2.4.1 CABG
This is a surgical procedure in
which arteries/veins from other parts of the body (usually the leg) are grafted into the coro-
nary artery to bypass the narrowed (stenotic) region. The bypass graft is connected from the
aorta to the post-stenotic region, thereby bypassing the blockage to maintain the downstream
blood-supply. Figure 2.5a shows the CABG procedure. CABG, owing to its highly invasive
nature is used only if the disease is severe or can’t be treated with angioplasty/stenting.10 Chapter 2. Introduction to coronary artery disease and stents
(a) Coronary artery bypass graft surgery [25]
(b) Angioplasty: procedure [26] (c) Stenting: procedure [26]
Figure 2.5: Treatment options for CAD
2.2.4.2 Angioplasty
Percutaneous transluminal coronary angioplasty (PTCA), is a minimally invasive procedure in
which a catheter, with a balloon mounted on the end, is inserted through the femoral/brachial
arteries to the stenotic region. Once the catheter is positioned in the stenotic region, the
balloon is inﬂated/deﬂated multiple times to compress the plaque against the artery wall. The
catheter, along with the deﬂated balloon, is then withdrawn without leaving any permanent
object inside the artery. Figure 2.5b shows the angioplasty procedure.
2.2.4.3 Stenting
Coronary artery stents are tubular metal structures (often meshes) which are inserted in the
stenotic region through a balloon catheter, usually after angioplasty, and then expanded until
they deform plastically to provide scaﬀolding support that prevents arterial recoil. After the
procedure, the metal stent remains inside the artery wall to prevent its recoil. Cells grow over
the stent after the procedure, making it a permanent part of the artery. Figure 2.5c shows
the procedure of stenting.
2.3 Issues with stenting: restenosis and thrombosis
The two most common issues that the use of angioplasty, with or without stenting, face today
are restenosis and thrombosis. The following sections describe both these issues.2.3. Issues with stenting: restenosis and thrombosis 11
(a) Restenosis in an artery cross sec-
tion after angioplasty [5]
(b) Restenosis in an artery cross




Although balloon angioplasty and stenting are widely used procedures today, restenosis con-
tinues to be a major problem associated with it. Dangas and Fuster [27] deﬁne restenosis
as the reduction in lumen size at the cite of an angioplasty/stenting procedure. Restenosis
is a result of arterial damage that leads to the formation and proliferation of neointima, a
new thick layer of intima, at the procedure cite and occurs in 40-50% of cases within six
months of the procedure [27, 28]. Figure 2.6 shows the occurrence of restenosis in coronary
arteries. Although, the advent of drug eluting stents (see section 2.4 for types of stents) has
signiﬁcantly reduced the rates of restenosis to a level just above 10%, its presence can not be
neglected as the number of patients treated with drug eluting stents is large [28]. Restenosis
is a complex multifactorial biological process, the causes and mechanism of which are not
completely understood [28, 29]. However, there are several factors which have been identiﬁed
to contribute towards restenosis. These factors are discussed individually in future chapters.
Restenosis is usually measured in the following three ways:
• Angiographically (binary restenosis)
• Clinically (target lesion revascularization (TLR))
• Late loss (LL)
Angiographic (binary) restenosis refers to more than 50% diameter stenosis at follow-up.
TLR is deﬁned as clinically driven repeat percutaneous intervention (PCI) of the lesion. It is
driven by clinical signs of ischemia, reduced downstream blood-ﬂow. TLR is most relevant to
the patients as it reﬂects the risk of them needing a repeat interventional procedure [5]. Late
loss, measured in mm, is the most quantitative deﬁnition of the restenosis rate. It is deﬁned as
Late Loss = (MLD immediately after procedure) - (MLD at follow-up)
where MLD denotes minimal lumen diameter.12 Chapter 2. Introduction to coronary artery disease and stents
2.3.2 Thrombosis
Thrombosis refers to the formation of a blood clot, thrombus, inside a blood vessel. The pres-
ence of a thrombus may either reduce the supply of downstream blood or completely occlude
the blood vessel. The extent of non-occlusive thrombosis depends on the extent of vessel
injury [5]. It is a result of incomplete healing where the exposed parts of the stent, or parts of
ruptured plaque, provide ideal sites for thrombogenesis. Figure 2.7 shows a picture of throm-
bus along with the lumen, neo-intima, and the plaque on a cross section of a human artery.
Figure 2.7: Thrombosis: artery cross sec-
tion of a patient that died after 10 months
of balloon angioplasty [5]
Rabbat et. al. [31] identify several procedural
and patient speciﬁc risk-factors that contribute
towards thrombosis. Late thrombosis (occurring
after 30 days of stent implantation) [31] is gen-
erally associated with drug eluting stents, which
elute an anti-proliferative drug into the arterial
tissue to prevent restenosis. As opposed to the
bare metal stents, drug eluting stents (see section
2.4 for diﬀerent types of stents) delay the process
of endothelialisation [32], the process of genera-
tion of endothelial cell layer post stenting pro-
cedure, and can trigger a thrombogenic response
leading to late thrombosis [33].
2.4 Stents: classiﬁcation and desirable properties
This section presents a classiﬁcation of stents based on various design parameters such as
materials, geometry etc. After discussing the classiﬁcation of stents, the properties that are
desirable in an ideal stent are outlined.
Stents can broadly be classiﬁed as bare metal stents (BMS), drug eluting stents (DES), and
bioabsorbable stents. BMS are made of metal only, and they may or may not have a biocom-
patible polymer coating. DES, on the other hand, necessarily have a drug coating, which is
most commonly bound within a polymer. The two most commonly used drugs are sirolimus
and paclitaxel. Both of these drugs are anti-proliferative which means that they interfere
with the cell growth/division cycle [30] and hence help in reducing restenosis. Biosbsorbable
stents are those made up of biodegradable materials that gradually degrade in roughly 12
months after the implant procedure depending on the type of biodegradable material used.
They may or may not have a drug coating. Early results showed vigorous inﬂammatory re-
sponse to bioabsorbable stents, but active research is currently being undertaken to develop
bioabsorbable stents [33].
Apart from the above mentioned broad classiﬁcation stents can further be categorized
according to various properties. The handbook of coronary stents [34] lists the details of 43
commercially available stents. Stoeckel et. al. [6], in 2002, classiﬁed nearly 100 diﬀerent com-
mercially available stents to diﬀerentiate them by their engineering properties. The following
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2.4.1 Nature of expansion
The most obvious classiﬁcation of stents is based on the nature of expansion. Stents can
either be balloon expandable or self expanding. Balloon expandable stents are made of metal,
usually stainless steel (316L), or alloys, such as platinum-chromium or cobalt-chromium, that
can plastically deform through balloon inﬂation. Self-expanding stents, on the other hand,
either rely on the elastic properties of the metal or are made up of shape memory alloys
(SMA), such as Nitinol (Nickel-Titanium), which can expand autonomously after release
from the delivery system.
2.4.2 Materials
The material of the stent depends on the nature of expansion and its bio-compatibility.
While most balloon-expandable stents are made of 316L stainless steel, a majority of self-
expandable stents are made of Nitinol. 316L stainless steel is a corrosion resistant material
with low carbon content with additions of molybdenum and niobium. Nitinol is an alloy
composed of 55% weight percent nickel and 45% titanium. In addition to stainless steel and
nitinol there are a number of other materials used to manufacture stents as tabulated in table
2.1. Recently, various metal alloys have emerged as a good alternative to stainless steel 316L,
for e.g. the latest Boston Scientiﬁc’s PromusTM ElementTMcoronary stent is made from a
Platinum-Chromium alloy and Medtronic’s Integrity stent is made from a cobalt-chromium
alloy. The advantage of using alloys is that they allow relatively thinner stent struts without
compromising structural strength.
Table 2.1: Stents classiﬁcation: materials
Type Material Example
Balloon expandable Stainless steel (316L) Bx VELOCITY stent
Tantalum Wiktor
Martensitic Nitinol Paragon
Paladium Iridium Angio stent
Polymers Ingaki-Tamai stent
Niobium alloy Iridium Lunar StarFlex
Cobalt-Chromium alloys Integrity and Xience stents
Platinum Chromium alloy Promus ELEMENT stent
Self Expanding Super elastic Nickel-Titanium
(Nitinol)
Cordis SMART
Cobalt alloy Iridium Wallstent
Full Hard Stainless Steel Cook Z-Stent
2.4.3 Manufacturing form
Stents can be made from sheet metal, wires, or slotted tubes. For sheet-metal stents, the
pattern is made on the sheet which is then rolled to form a tubular structure. Alternatively,
wires can be knitted or braided together to form tubular meshes. The majority of stents
available today are made from tubes, which are laser-cut to carve speciﬁc patterns on the
tube. Table 2.2 classiﬁes the stents based on their form.14 Chapter 2. Introduction to coronary artery disease and stents
Table 2.2: Stents classiﬁcation: form
Type Description Example
Sheet rolled to make a stent NIR stent
Wire knitted or braided together Wallstent
Slotted-Tube laser-cut Bx VELOCITY stent
2.4.4 Fabrication method
Depending on the form of the stent, diﬀerent fabrication methods can be used for manufac-
turing. Conventional wire-forming techniques like coiling, knitting or braiding are used to
form stents with wires. All coil stents available today are self-expanding and made of Nitinol.
Sometimes the wires after coiling are welded at certain locations to produce closed-cell wire
stents (e.g. the Symphony stent). For slotted-tube stents, laser cutting is typically used.
Balloon expandable stents are usually laser-cut in a crimped or near-crimped state and then
surface treated (for example electropolished). Alternatively, waterjet cutting can be used for
cutting out tubes (e.g. SCS stainless steel stent). This process does not produce a heat-
aﬀected zone along the cutting edge like that produced in the process of laser cutting. Lastly,
photochemical etching can also be used to manufacture stents. This process is currently used
to produce stents from tubing, but is also applicable in sheet processing to produce a large
number of parts in a single run.
2.4.5 Geometry
Classiﬁcation of stents based on geometry is the most interesting aspect of stent design. A
vast variety of stent designs are available today with contrasting geometrical features. One
of the main objectives of this thesis is to identify geometric properties that lead to better
results for restenosis rates. Initial stent designs started with simplistic geometries/patterns,
which over a period of time have evolved into more complex shapes. The following high level
categories were used for geometrical classiﬁcation of stents by Stoeckel et. al. [6]
2.4.5.1 Coil
Coil design is most common in non-vascular applications as a coil stent can be retrieved after
implantation. Coil stents are extremely ﬂexible. However, their strength is limited and they
have a low expansion ratio. Figure 2.8a shows the Esophacoil device with a coil design.
2.4.5.2 Helical spiral
These are helix shaped stents with no or minimal connections. Helical designs produce highly
ﬂexible stents but compromise on longitudinal support. Internal connections help the longi-
tudinal stability by compromising on ﬂexibility. Figure 2.8b shows the Crossﬂex stent with a
helical spiral design.
2.4.5.3 Woven
Woven stents are typically wire stents which have been knitted/braided together. Self-
expanding stents are often made of nitinol wires. Woven stents provide excellent wall coverage
but typically shorten during expansion. Moreover, their radial strength is highly dependent2.4. Stents: classiﬁcation and desirable properties 15
(a) Coil design (b) Helical Spring design
(c) Woven stent design (d) Closed cell with non-ﬂex links
(e) Closed cell with ﬂex links (f) Open cell design
Figure 2.8: Stent classiﬁcation based on geometry [6]
on axial ﬁxation at the ends. Figure 2.8c shows the Cook ZA stent which has a knitted nitinol
wire design.
2.4.5.4 Sequential rings
Sequential rings can be joined together at various points to make a stent. The rings can take
various shapes, the most common of which is a sequence of zig-zag Z-shaped elements to form
a ring. These rings can have various types of connections between them to form a complete
mesh. Commonly found connections are:
• Regular connections - connections at each tip of the Z-shaped elements
• Periodic connections - connections at a subset of the tips of Z-shaped elements which
repeat perodically
• Peak-peak or peak-valley connections
These connectors either are straight segments (non-ﬂex connectors) or ﬂexible (ﬂex con-
nectors). Another way to consider the sequential ring stents, more commonly applicable to
slotted-tube stents, is if they are closed cell or open cell:
• Closed cell designs - These are designs where all the tips of the structural members are
connected by bridging elements/connectors. Connectors can be either ﬂex or non-ﬂex,16 Chapter 2. Introduction to coronary artery disease and stents
but the combination should make closed cells. Figure 2.8d and ﬁgure 2.8e shows stent
designs with a non-ﬂex and ﬂex connector respectively.
• Open cell designs - These are designs produced by closed cell structures by eliminating
some/all of the bridges to open-up the closed cells. Open cell stents are usually more
ﬂexible than their closed-cell counterparts because the unconnected elements increase
longitudinal ﬂexibility. This category also entails stents which have no tip-tip connec-
tions but connectors originating from the middle of the struts (eg. BeStent). Figure
2.8f shows a picture of a stent with open-cell architecture.
2.4.6 Additions
A number of enhancements are added to stents, to improve their performance or visibility.
The following are the most commonly used enhancements:
• Radio-opaque markers - Gold markers to improve the visibility for stent delivery and
follow-up diagnosis
• Radio opaque coating - Gold or silicon-carbide coating to improve visibility
• Biocompatibility coating - Coatings of tantalum, phosphorylcholine, carbon, or silicon-
carbide
2.4.7 Based on major stent manufacturers
Stents can also be classiﬁed according the major manufacturers. Currently, the following are





In terms of engineering properties, the most widely studied drug eluting stent is the
CYPHER stent, manufactured until 20111 by Cordis Corporation, Johnson & Johnson com-
pany. CYPHER, although now discontinued, is a sirolimus eluting stent on the Bx VELOC-
ITY stent platform, i.e. the geometric shape of the Bx VELOCITY bare metal stent. Figure
2.9a shows a picture of the CYPHER stent. It has a closed cell design with ‘n’ shaped ﬂex
connectors. In contrast to the CYPHER stent, Boston Scientiﬁc’s TAXUS Libert´ e stent is
an open cell design and is a paclitaxel eluting stent. Figure 2.9b shows the TAXUS Lib-
ert´ e stent. Similarly, Boston Scientiﬁc’s Promus ELEMENT stent, an open cell everolimus
(derivative of sirolimus) eluting stent, is shown in Figure 2.9c. Xience V is the main DES
produced by Abbott Vascular (shown in Figure 2.9d). It has an open cell design and elutes
everolimus. Medtronic has a BMS stent, called the Integrity stent, and a DES, called the
Resolute Integrity stent. The Resolute Integrity stent is based on the Integrity stent plat-
form, and elutes zotarolimus, a synthetic derivative of sirolimus. The geometric platform
1Johnson & Johnson announced in June 2011 [35] that Cordis corporation will stop the production of
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1. be ﬂexible
2. have high radial stength
3. minimise arterial injury
4. minimise hemodynamic alteration
5. provide adequate drug delivery
6. facilitate uniform drug distribution (DD)
The ﬁrst point of ﬂexibility stems from ease of deliverability that is desired in an ideal
stent. The process of delivering a stent to the stenotic site involves manoeuvring through
arteries which can be highly curved and tortuous, thereby necessitating the need for high
ﬂexibility. High radial strength is analogous to provision of adequate arterial support. It
is important to meet the very idea of stent invention i.e. to prevent arterial recoil. The
rest of the four properties listed above relate to limiting the adverse responses of restenosis
and thrombosis. This relation between these properties and adverse responses are brieﬂy
discussed here, but are presented in detail in future chapters. Arterial injury caused during
the stenting procedure can be directly correlated with restenosis rates (see chapter 5). This
implies that an ideal stent should minimise the injury caused during deployment. Several
studies (see Chapter 4) have showed a link between altered haemodynamics in stented vessels
and restenosis rates. Consequently, a good stent should alter the haemodynamics minimally.
Since DES rely on an anti-proliferative drug to inhibit restenosis, a good stent should ensure
that adequate drug is delivered in the tissue. Moreover, depending on the toxic-to-therapeutic
ratio of the drug used, the drug distribution should be uniform across the tissue surrounding
the coronary lesion.
As will be discussed in future chapters, the geometrical features of a stent design dictate
all the aforementioned features. This leads to the conclusion that it should be possible to
alter stent geometry to improve the aforementioned properties, and consequently minimise
adverse responses. However, the consideration of numerous conﬂicting factors while designing
a stent presents a major challenge. A change in stent geometry leading to an improvement
in one of the desirable characteristics often leads to degradation in one or more of the other
characteristics. As a result, the consideration of all the desirable characteristics, all originating
from one stent design, lead to a very complex multi-objective and multi-disciplinary design
problem.
A major part of this thesis deals with this design problem. In future chapters, the afore-
mentioned desirable properties are quantiﬁed, so that given two geometrically diﬀerent designs
a judgement regarding the superiority of one over the other, in terms of a particular desired
characteristic can be made. Thereafter, two studies, one based on a constrained optimisation
formulation and one based on a multiobjective formulation, are presented as potential solu-
tions to the stent design problem. Before concluding this chapter, various approaches that
are adopted to create computer aided design (CAD) models of stents is brieﬂy presented in
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2.6 CAD geometry construction
The ﬁrst step to evaluate any property of a stent computationally is the construction of its
computer aided design (CAD) geometry. Rhinoceros 4.0 (Robert McNeel & Associates), a
commercially available NURBS (Non-uniform rational basis splines) based modelling software,
is used for this purpose. The following subsections describe various approaches that can be
employed to construct full 3-D stent geometries.
2.6.1 Approaches to model a stent
Figure 2.9 shows a few contemporary stent designs. Most stent designs used today in clinical
practice today are slotted-tube type. Three approaches can be used to model such stent
geometries:
• Approach 1: The base geometry in this approach is a cylindrical shell with the required
thickness of the stent. Cell patterns are then cut out (boolean diﬀerence) from this base
geometry to obtain the stent geometry.
• Approach 2: In this approach the base geometry is a plane sheet of required thickness.
The cell patterns, like in approach 1, are cut out from this plane sheet, and the resulting
structure wrapped/mapped on to a cylindrical shell to obtain the ﬁnal stent geometry.
• Approach 3: This approach uses curves (splines or NURBS) to model the shape of
the stent struts on a ﬂat plane. The resulting network of curves is then converted into
a closed surface, extruded to the required height, and mapped on to a cylindrical shell
to obtain the ﬁnal stent geometry.
Depending on the stent design, one of the above methods can be used. If the pattern
is easy to construct and periodically repeating, then either of the ﬁrst two methods can be
used. However, if the patterns in the stent design are not so apparent, and the shape consists
of non-periodic or complex shapes, the third option proves very powerful to construct 3-D
models.
Approaches 1 and 2 are similar, but it is more diﬃcult to cut the patterns out from
a cylindrical shell than from a ﬂat sheet/plate. Hence, either of approaches 2 and 3 are
used for constructing stent geometries in future chapters. The following subsections describe
approaches 2 and 3 in more detail.
2.6.1.1 Approach 2
Figure 2.10a shows the starting geometry, a ﬂat plate, used in this approach. A periodic
pattern similar to the Palmaz-Schatz stent is created (Figure 2.10b). This pattern is a solid
which can be made by outlining the pattern with closed curves (usually NURBS), converting
them to a surface, and then extruding the surface to the required height. This pattern is
then repeated periodically to ﬁll in the base plate (see Figure 2.10c). After this a boolean
subtraction operation is performed on the ﬂat plate with the solid patterns, which results in
the ﬂat geometry of the stent (Figure 2.10d). This ﬂat structure can then be rolled around a
cylinder to obtain the ﬁnal stent model, as shown in Figure 2.10e.20 Chapter 2. Introduction to coronary artery disease and stents
(a) The ﬂat plate (b) Cutting Pattern
(c) Array of the cutting patterns (d) Stent in its ﬂat conﬁguration (a)-(c)
(e) Flat stent rolled to get a cylindrical shape
Figure 2.10: Approach 2 to construct stent geometry
2.6.1.2 Approach 3
This approach requires the stent struts to be modelled with the help of curves, splines or
NURBS, to create a network of curves(Figure 2.11a). This network is then closed and con-
verted into a surface or a collection of surfaces (Figure 2.11b). Thereafter these surfaces are
extruded to a height equal to the required strut thickness (Figure 2.11c) to obtain the ﬂat
geometry of the stent. This ﬂat geometry can then be wrapped around a cylinder to obtain
the ﬁnal stent (Figure 2.11d).
Figure 2.12 shows 3-D stent models constructed using the three approaches mentioned above.
2.6.2 Pre-crimped state models
The approaches discussed above show how the ﬁnal expanded state geometries can be created.
In reality stents are manufactured, for example laser cut, in a pre-crimped state, whose
diameter is usually lower than the ﬁnal diameter when expanded. These pre-crimped stents
are then crimped, through crimping machines, to further decrease the diameter and enable
mounting on a delivery system. Thus, to model the expansion process of the stents, pre-2.7. Conclusions 21
(a) The Curves outlining the geometry (b) Surfaces made from curves
(c) Extrude srufaces to make ﬂat solid (d) Flat stent rolled to get a cylindrical shape
Figure 2.11: Approach 3 to construct stent geometry
crimped or crimped state geometrical models of the stents, depending on whether the crimping
process is modelled or not, are needed. This does not present any diﬃculty in terms of CAD
modelling of stents as the dimensions, for example the width of the ﬂat plane and the radius
of the cylindrical shell used for mapping, can be altered to create stent geometries in any
required dimensions. Figure 2.13 shows the two crimped state representative models for the
Bx VELOCITY and Xience V stents, both created using approach 3.
2.7 Conclusions
This chapter has introduced coronary artery disease, its treatment options, and issues related
to its most common treatment, coronary stenting. Furthermore, a survey of a variety of
coronary stents and their classiﬁcation is presented. Thereafter, the properties that are
desirable in an ideal coronary stent are brieﬂy outlined. These properties are discussed
individually in future chapters. Lastly, computer modelling approaches to create geometries
of both expanded and pre-crimped state stents are presented.
Before moving on to computational analysis of stents based on the desired properties, the
next chapter presents an introduction to surrogate modelling and optimisation methodologies
that are employed in future chapters.22 Chapter 2. Introduction to coronary artery disease and stents
(a) Approach 1 (b) Approach 2
(c) Approach 3
Figure 2.12: Stents modelled from the three approaches
(a) Crimped state model of the Bx VELOCITY stent (b) Crimped state model of the Xience V stent
Figure 2.13: Crimped state models created using approach 3Chapter 3
Introduction to surrogate modelling
and optimisation methodologies
This chapter presents an introduction of surrogate modelling and optimisation methodologies.
First, a need for surrogate modelling and the basic formulation of the surrogate model used
in this thesis, i.e. the Gaussian Process model, is presented. Thereafter, along with an
introduction to various optimisation methodologies, the optimisation framework adopted in
this thesis is presented.
3.1 What is optimisation?
In the most general sense optimisation can be deﬁned as the process of “ﬁnding and com-
paring feasible solutions until no better solution can be found” [36]. Here, ‘solutions’ refer
to diﬀerent designs of the problem at hand, for example in the case of aerodynamic wing
design solutions might refer to the diﬀerent shapes of the wing; in the case of bridge design
solutions might refer to the diﬀerent structures which the bridge can take; and in the case
of pharmaceutical drug design, it might refer to drugs produced by diﬀerent combinations
of individual drug components. Hence, one design can be thought of as a combination of
several decision variables, where each decision variable can take multiple values. Decision
variables in the case of wing design could be the location of NURBS control points that
deﬁne the shape of the wing; for bridge design it could be the network (i.e. nodal locations
and connectivity) of trusses and the lengths, cross-sections, materials etc. for each truss;
and for drug design they could be the mole-fraction of each individual drug component. A
‘better’ solution in the deﬁnition refers to comparison with regards to a goal. For example,
in the case of wing design the goal could be to achieve minimum drag; for bridge design
the goal could be to achieve minimum weight; and for drug design the goal could be to kill
maximum cancerous cells. In all of the tasks the goal would involve either maximisation or
minimisation (collectively known as optimisation) [36] of a goal. Optimisation procedures
that have only one goal are known as single-objective optimisation procedures, and those
that have more than one goal are known as multi-objective optimisation procedures, where
the goal is to simultaneously minimise or maximise two or more goals. For example, in wing
design the two goals could be to minimise drag and maximise lift; for bridge design the goal
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of the hypervolume. In contraction one vertex is displaced towards the opposite face, and in
multiple contraction, a face is displaced towards the opposite vertex. The process is repeated
until the hypervolume of the simplex reduces to a size less than a pre-speciﬁed convergence
limit.
3.3.4.2 Evolutionary methods
Evolutionary Algorithms (EA) are algorithms that mimic evolutionary processes found in
nature for optimisation [36]. Keane and Nair [18] identify two features common to all evo-
lutionary algorithms: ﬁrst, that these algorithms employ random numbers, and hence the
repeated application of the same algorithm with identical parameters and starting points
yields diﬀerent search trajectories to locate optimal solutions; and second, that all such algo-
rithms are global optimisation algorithms, i.e. locally optimal solutions might be discarded
during the search process. The most well-known EAs are genetic algorithms, simulated an-
nealing, evolution strategies, evolutionary programming, and particle swarm optimisation.
Here, one of these methods, genetic algorithms, is discussed.
3.3.4.3 Genetic algorithms
Genetic algorithms (GAs), due to their wide applicability and documented success, have be-
come a popular choice for optimisation procedures [36, 61]. As opposed to classical algorithms
for optimisation that work with a single point at a time, GAs work with a population of points.
An initial population is ﬁrst created randomly in a search domain; then, at each iteration
the members of the this population undergo selection, crossover, and mutation to create the
next generation. As this process is repeated, the average ﬁtness (representing the goodness
of solution(s)) of the population increases, thereby moving towards the global optimum of
the problem at hand. To represent solutions in a population, a representation of candidate
solutions is needed. An important distinction among GAs is made in this regard. GAs that
represent candidate solutions (phenotypes) as strings of binary bits (genotypes) are known as
Binary coded GAs. In such GAs each binary string is mapped on to the real space in order
to calculate ﬁtness values. On the other hand GAs that work directly on real variables are
called Real coded GAs. The working principles of a GA can be succinctly described by the
following steps [36]:
Representaion: As mentioned above a candidate solution can either be represented as
a string of binary bits (sections of which correspond to diﬀerent variables), or real
variables (no mapping needed).
Fitness assignment: Each candidate of the population is assigned a ﬁtness value based on
the objective function value at that point. Many schemes exist for such assignment, for
example, ﬁtness of a candidate can be equal to the objective function, an appropriately
scaled value of the objective function, rank of the candidate in the population, etc.
Selection: The selection operator is the ﬁrst genetic operator that is applied to the popu-
lation in order to select candidates for a mating pool (i.e. for future genetic operators).
Its goal is to create more copies of strong (having relatively high ﬁtness value) candi-
dates while diminishing the number of weak candidates (relatively low ﬁtness value).Chapter 4
Haemodynamics in stented vessels
This chapter1 primarily deals with haemodynamic evaluation of coronary stents, i.e. to study
how the ﬂow features in stented vessels are related to the design features of a stent. This re-
lation is made within the currently accepted paradigm for the causes of in-stent restenosis. In
subsequent chapters, other factors including arterial injury, drug-distribution, and ﬂexibility
are evaluated. The aims of this chapter are
1. to set up a computational ﬂuid dynamics (CFD) model to evaluate blood ﬂow in a
stented segment of a coronary artery,
2. to compare ﬂow features relevant to restenosis (cf. section 2.3.1) in ﬁve diﬀerent coro-
nary stents, and
3. to formulate an objective function that quantiﬁes haemodynamic alteration, relevant to
restenosis, that can be used in optimisation studies.
This chapter begins by a review of studies – in vivo, computational, and experimental –
that identify a potential link between altered haemodynamics and restenosis. Thereafter, the
details of the CFD model are presented, and the results of the comparison of ﬂow features
between ﬁve diﬀerent stents are discussed. Finally, a computationally measurable objective
function that can be used to compare stents based on haemodynamic alteration is formulated.
4.1 Introduction
Though coronary stent designs have evolved signiﬁcantly over the past two decades, they
still face the problem of in-stent restenosis, formation of neo-intima within six-months of the
implant. Studies show that biological response post stent implantation depends on various
factors including the stent design and how it alters the haemodynamics. This chapter takes
ﬁve diﬀerent stent designs, representing diﬀerent coronary stents used in clinical practice,
1The contents of this chapter are published in the below mentioned article. Dr. A.I.J Forrester, as the
author’s then co-supervisor, contributed to this article through discussions, and Dr. N. Curzen is a cardiac
surgeon who actively advises the author regarding the clinical aspects of restenosis.
Pant, S., Bressloﬀ, N. W., Forrester, A. I. J. and Curzen, N. The inﬂuence of strut-connectors in stented vessels
: A comparison of pulsatile ﬂow through ﬁve diﬀerent coronary stents. Annals of Biomedical Engineering,
38:1893–1907, 2010.
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and explores the haemodynamic diﬀerences arising due to the diﬀerences in their design. Of
particular interest is the design of the segments that connect two struts. Pulsatile blood
ﬂow analysis is performed for each stent, using 3-D CFD, and various ﬂow features viz.
recirculation zones, velocity proﬁles, wall shear stress (WSS) patterns, and oscillatory shear
indices are extracted for comparison. Vessel walls with abnormal ﬂow features, particularly
low, reverse & oscillating WSS, are usually more susceptible to restenosis. Unlike previous
studies, which have considered the eﬀect of design parameters such as strut-thickness and
strut-spacing on haemodynamics, this chapter investigates the diﬀerences in the ﬂow arising
purely due to diﬀerences in stent-geometry, other parameters being similar.
The following subsections review the studies which show the eﬀect of ﬂow disturbance on
restenosis.
4.1.1 Eﬀect of stent design: in vivo studies
Kastrati et al. [80] analysed 4,510 patients with stent implantations and showed that ves-
sel size and stent design were ﬁrst and second most important factors aﬀecting restenosis,
respectively. In their analysis, which predominantly used eight diﬀerent types of stents, it
was found that, depending on the stent design, the incidence of restenosis varied between
20.0% to 50.3%. Rogers and Edelman [81] studied denuded rabbit iliac arteries after im-
planting steel stents for 14 days. They reported that stent material and conﬁguration were
critical factors in determining intimal hyperplasia and thrombosis. By comparing two stents,
with the same surface area and mass but diﬀerent strut-strut intersections, they reported
that reducing strut-strut intersections signiﬁcantly reduced vascular injury, thrombosis, and
neointimal hyperplasia. Kastrati et. al. [82] performed an analysis over 651 patients, in which
coronary stents of similar designs but diﬀerent strut-thickness were implanted, and reported
that reduction in strut-thickness resulted in signiﬁcant reduction in angiographic and clinical
restenosis.
From the point of view of altered haemodynamics, a signiﬁcant body of evidence suggests
that sites with low mean shear stress, oscillatory shear stress, high particle residence times,
and non-laminar ﬂow are the sites where most intimal-thickening occurs. Ku et. al. [83,
84] reported a strong correlation between low mean wall shear stress (less than 0.5 Pa)
and atherosclerotic intimal thickening in human carotid bifurcations. They also reported
that regions experiencing oscillating shear stress may enhance atherosclerosis. Moore et. al.
[85] studied intimal thickening in 15 post-mortem aortas and reported that in the region
of the infrarenal aorta, vessel regions exposed to low mean and oscillating WSS are more
inclined to the development of plaque when compared to regions exposed to high WSS.
Wentzel et. al. [86] studied neointimal thickness in 14 patients after 6-months of Wallstent
implantation. They used a 3-D reconstruction of arteries to determine neointimal thickness
and computational ﬂow analysis to calculate shear stress on the surface of the stent. For 9
out of 14 implantations they observed that neointimal thickening and in-stent shear stress
were inversely correlated. The aforementioned studies suggest that stent design, which leads
to speciﬁc WSS patterns, is a key determinant of restenosis rates.4.1. Introduction 51
4.1.2 Eﬀect of stent design: studies on altered haemodynamics
This section reviews computational and experimental studies that have identiﬁed a link be-
tween stent design and haemodynamic alteration.
4.1.2.1 Computational Studies
Computational ﬂuid dynamics provides an excellent tool for studying micro features of the
ﬂow and has been widely used for ﬂow analysis through stented vessels. Berry et. al. [87]
performed experimental and 2-D computational ﬂow analysis using custom-made models of
a braided wire stent, Schneider Wallstent
R  , to reveal ﬂow separation and formation of stag-
nation zones between wires. They studied the eﬀect of wire spacing and diameter on the
stagnation zones and reported that stent geometry had a signiﬁcant eﬀect on arterial haemo-
dynamics. In particular, their ﬁndings concluded that the ﬂuid stagnation zones are contin-
uous if wire spacings in the stent design is less than six wire diameters. Ladisa et. al. [88]
performed steady state 3-D CFD simulations in a Palmatz-Schatz slotted-tube stent using
data from in vivo measurements of canine left anterior descending coronary artery diameter
and blood ﬂow velocity. They reported that regions of low wall shear stress are localized
around stent struts. They also suggested that angled struts that are aligned in the direction
of the ﬂow could minimise ﬂow disturbances. In another study they [89] reported that while
reducing the number of struts and strut-thickness reduced the percentage of arterial wall
area exposed to low wall shear stress, the opposite was observed if strut-width was decreased.
Rajamohan et. al. [90] studied pulsatile & non-Newtonian blood ﬂow through a stent with a
helical strut matrix and identiﬁed recirculation zones immediately upstream and downstream
of each strut intersection. Their investigation suggested that such areas could be more sus-
ceptible to restenosis. Similar other studies [91, 92, 93, 94] have shown that stents, depending
on their design, cause signiﬁcant alterations in haemodynamics leading to particular zones
which could be susceptible to smooth muscle cell proliferation and restenosis.
Seo et. al. [91] studied haemodynamic disturbances induced by stents in straight and
curved segments of vessels. They suggested that in curved segments the diﬀerence in WSS
patterns between the outer and inner walls depends on the vessel curvature and the ﬂow
Reynolds number in a complex manner. They studied the ﬂow for two diﬀerent designs,
one with spiral structure and one with an intertwined ring structure, and revealed that the
stent-design had a major eﬀect on the ﬂow disturbances. Balossino et. al. [95] modelled
expansion of four diﬀerent stents against plaque and artery using ﬁnite element analysis and
used the expanded geometries to evaluate the haemodynamics. They compared the WSS
distribution for these stent models and also studied the eﬀect of strut-thickness on vessel
haemodynamics. In particular, they reported high wall shear stress values at the centre of
the stent cells and a decreasing trend in wall shear stress as one moved away from the centre
towards the stent struts. The aforementioned computational studies re-aﬃrm the role of stent
design in determining WSS in stented artery segments, and hence restenosis rates.
4.1.2.2 Experimental Studies
Some experimental studies have been performed which employ various methods like dye
injection ﬂow visualization and particle image velocimetry. Peacock et. al. [96] used an
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of stented segments and used alumina particles for ﬂow visualization. They detected ﬂow
instabilities 1 cm downstream, and no instabilities were found 5 cm downstream, for mild-
exercise conditions. Berry et. al. [87] used dye injection ﬂow visualization and reported
accumulation of dye at each strut-strut intersection. Benard et. al. [97] used a programmable
pump and particle image velocimetry to investigate laminar ﬂow over stents and identiﬁed
zones around the stent struts that had low WSS. Such experimental studies imply a correlation
between the stent design and ﬂow instabilities in stented vessels, particularly in and around
the stent-struts.
4.1.3 Studies on endothelial cell response
Relatively few studies exist which investigate the response of endothelial cells to haemody-
namics in stented vessels. DePaola et. al. [98] showed by in vitro experiments that the
vascular endothelium responds to shear stress gradients. They reported that endothelial cells
migrate from areas where shear stress is low but the shear stress gradient is large, and that
cells remaining in such regions divide at a faster rate compared to the cells exposed to uni-
form shear. Nagel et. al. [99] reported that alteration of blood ﬂow leads to diﬀerential WSS
gradients that modulate endothelial gene expression at atherosclerotic prone sites. Yeh et. al.
[100] compared the growth of endothelial cells on diﬀerent stent materials. They concluded
that endothelial cell growth and protein expression level varies widely depending on the metal
sheet used. In particular, for all seeding levels, they found that endothelial cell growth was
high for TiN and TiO2 when compared to 316L stainless steel and nitinol.
Although many studies have tried to understand the eﬀect of stent geometry on altered
haemodynamics, most have focussed on the eﬀect of strut spacing and strut thickness. This
chapter deals with the eﬀect of stent shape on haemodynamics. Connectors (mostly ﬂex) are
an essential component of a stent-design as their presence makes the stent ﬂexible, which in
turn improves stent deployment. With the new stent designs now used in clinical practice,
especially drug eluting stents, there comes a need to study the eﬀect of these connectors,
along with the overall geometry, on haemodynamics. In order study these eﬀects a CFD
model is developed. This model forms the content of next section.
4.2 Methodology
4.2.1 Geometry
The ﬁve stents used in this chapter resemble the ART stent [8], Bx VELOCITY stent [34],
NIR stent [34], the MULTI-LINK Zeta stent [34], and the Biomatrix stent [101]. These stents
are chosen to represent a wide range of stent geometric shapes: the ART stent has straight
connectors, the NIR, Bx VELOCITY, and MULTI-LINK ZETA stents have diﬀernt complex-
ity of the curved connectors, and the Biomatrix stent does not follow quarter-symmetry like
the other stents. The details of each stent are listed in table 4.1.
In order to make a comparison between the stents, representative geometries for each
stent are constructed with the same diameter (3 mm), length (8 mm), strut width (0.05 mm),
and strut thickness (0.10 mm). Strut thickness represents the radial dimension of the struts
and strut width represents the circumferential dimension. It should be noted that the strut
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Table 4.1: Stents: details
Stent Manufacturer Referred as
ART stent Arterial Remodelling Technologies Stent A
BxVELOCITY stent Johnson & Johnson Stent B
NIR stent Boston Scientiﬁc Stent C
MULTI-LINK Zeta Abbott Vascular Stent D
Biomatrix stent Biosensors Stent E
Figure 4.1: Flat geometries for the ﬁve stents – left top: Stent A, left mid: Stent B, left
bottom: Stent C, right top: Stent D, right bottom: Stent E
extent, from the actual spacings for each of the stent designs. Figure 4.1 shows the ﬂattened
out geometries for one quarter of each stent except for Stent E, for which a half section
is shown. The straight lines drawn in each model deﬁne the line on the artery wall along
which wall shear stress and modiﬁed oscillatory shear index (MOSI) values are calculated
and compared in subsequent ﬁgures. For all ﬂow simulations the stent is placed at the centre
of the artery with an axial distance of two times the artery diameter on both the proximal
and distal ends of the stent. The artery wall is assumed to be straight with a constant
diameter. Figure 4.2 shows the stent-artery assembly for Stent B. Numerical simulations
are performed over a quarter of the stented segment for all stents, except for Stent E for
which a half segment (owing to the quadrature links which do not allow quarter symmetry)
is used, to exploit the periodic symmetry of the stent-artery assembly. All the geometries are
constructed in Rhinoceros 4.0, a NURBS-based CAD modelling tool (1993 – 2008, Robert
McNeel & Associates). Approach 2 (section 2.6.1.1) is used to construct Stent A while all
the other stent models are created using approach 3 (section 2.6.1.2). Figure 4.3 shows the
full 3-D models of the ﬁve stents.
4.2.2 Governing Equations
The following mass conservation (equation 4.1) and momentum conservation (equation 4.2)
equations are solved over the computational ﬂow domain of the stent-artery assembly:
∇.(v) = 0, (4.1)54 Chapter 4. Haemodynamics in stented vessels
Figure 4.2: Stent-artery assembly for Stent B
(a) Stent A (b) Stent B
(c) Stent C (d) Stent D
(e) Stent E
Figure 4.3: 3-D models of the stents used in this chapter58 Chapter 4. Haemodynamics in stented vessels
4.3 Results
The ﬂow features in the stented vessels are reported both qualitatively and quantitatively. In
particular, diﬀerences in wall shear stress patterns, recirculation zones, and oscillatory shear
indices are reported, thereby conﬁrming the eﬀect of stent design, especially the connectors,
on haemodynamics of stented vessels. Furthermore, the connector design in Stent C is varied
to study the eﬀect of connector length, in the cross ﬂow direction, on ﬂow features.
Figure 4.6: Axial WSS at point 5: Stents A-E from top to bottom
4.3.1 Wall Shear Stress
Wall shear stress follows a general trend for all the stents except for the regions between the
connectors. Figure 4.6 shows the general axial WSS patterns for all stents at point 5, the
point of maximum inlet velocity on the cardiac pulse. For all ﬁve stents, axial WSS has a
high value proximal to the stent and a relatively lower value in the area occupied by the
stent. Artery wall area distal to the stent experiences a higher axial WSS again as the ﬂow
disruptions minimize due to absence of stent struts. For Stents D and E, a larger artery
area is exposed to relatively low WSS (green area in Figure 4.6 after the stent ends) , when
compared to Stents A, B, and C, at the distal end of the stents. For all stents, and more
notably for Stents A, B, and C in Figure 4.6, axial WSS at the centre of the struts decreases
for consecutive struts in the direction of the ﬂow (transition from red to yellow in consecutive
struts). The artery wall region around the ﬁrst strut experiences a relatively high WSS as4.3. Results 59
Figure 4.7: Axial WSS for all stents along the central line at Point 3
compared to the area around other struts. The areas of low WSS are found to be localised
around the stent struts. This is in agreement with earlier ﬁndings of Ladisa et. al. [88] and
Rajamohan et. al. [90].
Recirculation zones are formed at the proximal and distal end of each strut/strut-connector
intersection, which cause the WSS to change sign before and after each strut/strut-connector
intersection. In Figure 4.6 the blue regions show the artery wall area with negative axial
WSS implying formation of recirculation zones. The phenomenon of recirculating ﬂow is
particularly signiﬁcant in the decelerating phase of systole (point three, cf. Figure 4.4) as the
recirculation zones are largest during this phase. Figure 4.7 shows the axial-WSS variation,
along a central line on the arterial wall (as shown in Figure 4.1), for the ﬁve stents at point
3 of the cardiac pulse. For all stents the WSS values proximal and distal to the ends are
the same. In between the struts WSS recovers from zero to a peak value which decreases for
consecutive struts in the direction of ﬂow. This peak value is diﬀerent for all the stents and
depends on the overall stent design. Depending on the design of the strut connectors WSS
oscillates spatially in the connector region between zero, negative, and a positive value. In
contrast to other stents, Stent C connectors allow the WSS to recover to a positive value in
between the struts (as apparent in Figure 4.7). This can be attributed to the fact that Stent
C connectors have more open space between the connectors.
Previous studies [83, 104] suggest that areas exposed to WSS magnitude of less than 0.5
Pa correlate to areas that show most intimal thickening. Balossino et al. [95] have used
this 0.5 Pa limit as a benchmark to compare the performance of stents. Figure 4.8a shows a
histogram of the percentage of vessel wall area, over the axial length occupied by the stent,
exposed to WSS less than 0.5 Pa, at the eight points listed in table 4.2. At points 1 and 3
this area is 100% irrespective of the stent as the ﬂow is decelerating in the systole phase of
the cardiac cycle. Point 2, also in the systole phase, shows unexpected behaviour of less than60 Chapter 4. Haemodynamics in stented vessels
100% area exposed to low WSS. However, the reason for this becomes clear when considering
the negative WSS in Figure 4.8b. Other points show considerable diﬀerence in the area
exposed to low WSS which can be used to compare their performance. Stent A outperforms
the other stents at all points except Point 2. Stents D and E have a signiﬁcantly higher
percentage of low WSS area as compared to the other stents. While the diﬀerence between
Stents B and C is not very large, Stent C has a slightly higher area exposed to low WSS.
Another factor that could promote restenosis is negative WSS caused by reverse ﬂow.
Figure 4.8b shows a histogram of the percentage vessel area exposed to reverse ﬂow at the
eight points for all stents. Point 2, owing to the negative inlet velocity and a hence strong
reverse ﬂow, has the highest percentage area exposed to reverse ﬂow. While points 1 and 3
show no diﬀerence in terms of the 0.5 Pa WSS benchmark, these points show very signiﬁcant
diﬀerences in the area exposed to reverse ﬂow. Stent A, although outperforming other stents
at most points shows a near 100% area exposed to reverse ﬂow at point 2.
(a) Percentage vessel wall area below 0.5 Pa WSS magnitude
(b) Percentage vessel wall area exposed to reverse ﬂow
Figure 4.8: Percentage vessel wall area exposed to low WSS & reverse ﬂow
4.3.2 Recirculation zones
The presence of a stent inside the vessel gives rise to the formation of recirculation zones.
Figure 4.9 shows the recirculation zones formed between the struts and the connectors of all4.3. Results 61
the stents at point 3 of the cardiac pulse. Each segment in the connector design gives rise
to one recirculation zone. For instance Stent B has four recirculation zones in the connector
region while Stent D has ﬁve.
(a) Stent A
(b) Stent B (c) Stent C
(d) Stent D (e) Stent E
Figure 4.9: Recirculation zones at point 3
Figure 4.10, shows the velocity proﬁle adjacent to the artery wall for Stents B, C, and D
at point 3 of the cardiac pulse. Recirculation zones in the cross ﬂow direction are observed for
these designs close to the artery wall. This can be attributed to the fact that the connectors
in these designs, owing to their wavy nature, protrude into the space between the struts and
hence cause more alteration in the ﬂow.
4.3.3 Modiﬁed oscillatory shear index
For all the ﬁve stents modiﬁed oscillatory shear index is calculated using equation (4.6) along
the central line in the artery wall as shown in Figure 4.1. MOSI is important as this index
gives a time average value and hence is a measure of axial WSS over the entire pulse as
opposed to single points in time. MOSI values of ‘1’ or ‘-1’ indicate that the axial WSS is
positive or negative over the entire cardiac pulse respectively. Figure 4.11 shows a plot of
MOSI values along the central line mentioned above. Each plot shows the MOSI values for62 Chapter 4. Haemodynamics in stented vessels
Figure 4.10: Stents B, C, and D : Secondary recirculation zones
the one connector-strut-connector segment from the assembly.
4.3.4 Variation in Stent C
In order to further investigate the eﬀect of connector shape on haemodynamics, the design of
the connector in Stent C is varied. Keeping the thickness constant, its length in the cross-ﬂow
direction is varied. This changes the area between the struts that is covered by the connector.
Figure 4.12 shows the two altered designs – one with a shorter cross-ﬂow length and one with
a longer cross-ﬂow length. These are referred as Stent C-SC and Stent C-LC, respectively.
Simulations are carried out for these designs and the results are compared with Stent C.
Figure 4.13 shows a comparison of percentage vessel area below 0.5 Pa and Figure 4.14 shows
a comparison of percentage vessel area exposed to reverse ﬂow for Stent C and its variations.
4.4 Discussion and formulation of objective function
WSS, recirculation zones, MOSI, and results for all stent designs are reported above. While
the general qualitative features of WSS, such as localisation of low WSS regions around struts,
match those described in earlier studies [88, 89, 90, 87, 92], this chapter brings forth ﬁner
diﬀerences at diﬀerent parts of the cardiac pulse by comparing the factors that could have an
eﬀect on restenosis rates. Such diﬀerences, when compiled over the entire cardiac pulse, can
be used to compare the relative haemodynamic performance of various stents.
Areas of low WSS (less than 0.5 Pa) and reverse ﬂow are found for all the stents during
the entire cardiac cycle. For points 1 and 3, 100% of wall area is exposed to low WSS. This4.4. Discussion and formulation of objective function 63
Figure 4.11: MOSI values for a strut with connectors in each side
Figure 4.12: Variations in Stent C : top: normal, mid: shorter, and bottom: longer connectors4.4. Discussion and formulation of objective function 65
Figure 4.15: AWI for all stents for one cardiac pulse
WSS – because of the relatively lower strut spacing. However, even though Stents A, B, and
C, have the same strut spacing, percentage areas exposed to low WSS diﬀer signiﬁcantly.
Similarly, for all points there are signiﬁcant diﬀerences in the percentages of area exposed
to reverse ﬂow between stents A, B, and C. This can be attributed to the diﬀerence in the
design of the connector.
The connectors in Stents B,C, and D have a ﬁnite length in the cross ﬂow direction – this
cross-ﬂow area coverage being largest for Stent C. Consequently, the struts tend to project
into the central part of the space between struts. This causes a further disruption of the
ﬂow in that area - illustrated by Figure 4.10 which shows the velocity proﬁle adjacent to the
artery wall at point 3 in the cardiac pulse. Recirculation in the top ends of the connectors is
clear in these designs. Such a phenomenon is absent in Stents A and E as the connectors are
a straight segment joining the struts. The diﬀerence of such a protruding connector design
is further conﬁrmed when Stent C is altered to make the connector shorter and longer in the
cross-ﬂow direction (Stent C-SC and Stent C-LC). It can be seen in Figures 4.13 and 4.14
that areas exposed to low WSS and reverse ﬂow are proportional to the connector length in
the cross-ﬂow direction.
Traditionally [90], MOSI has been used to quantify the oscillatory nature of WSS. In
Figure 4.11 we see that MOSI takes a value close to ’-1’ at each strut-connector intersection
and between the connectors. This implies incessant reverse ﬂow or formation of recirculation
zones over a large part of the cardiac cycle at such points. In Stents B and D, due to the
presence of multiple gaps in the connector design multiple areas of persistent reverse ﬂow
are formed. This is consistent with the results of dye injection ﬂow visualisation studies [87]
where more dye accumulation was observed at each strut-strut intersection. The number of
recirculation zones formed is directly related to the design, speciﬁcally the number of gaps
either between struts or between the connector; see Figure 4.9 which illustrates this point.
However, the recirculation lengths depend on the overall strut-connector-strut conﬁguration.Chapter 5
Balloon expansion of stents
This chapter deals with the numerical modelling of the expansion process of balloon-expandable
stents inside a stenosed artery. Such modelling is essential for the following three reasons –
• to investigate the acute recoil after the stenting procedure,
• to investigate the stress-strain distribution in the stent and the arterial tissue, and
• to obtain the post-stenting geometry of the stent, plaque, and the artery, which can be
used in haemodynamic models developed in chapter 4.
As discussed in section 2.5, an ideal stent should have high radial strength. This radial
strength can be measured in term of the acute recoil after expansion of the stent. Further-
more, in order to minimise arterial injury due to the stenting procedure, an evaluation of
the stress-strain environment in the stented segment of the artery is needed. Lastly, the post
stenting geometry of the stented vessel is needed for accurate evaluation of haemodynamics
as discussed in chapter 4. In this chapter ﬁnite element analysis (FEA) models are developed
to meet all these objectives. In particular this chapter has the following aims
1. to develop a balloon-expansion model of a stent against the plaque in a representative
model of a diseased artery,
2. to quantify structural strength of a stent in terms of acute recoil, and
3. to quantify the change in the mechanical stress-strain environment after the stenting
procedure.
This chapter is organised as follows. In the ﬁrst section, a review of a) studies which show
a correlation between arterial injury and restenosis, and b) various approaches employed by
researchers to model expansion of stents is presented. Thereafter, the expansion modelling
approach adopted in this thesis is presented. Two sets of expansion are modelled. First, a
free expansion of a stent, i.e. without the presence of plaque and artery, using a balloon is
presented. This is primarily done to validate the obtained numerical results with manufacturer
data (in-vitro testing without the resistance of a vessel). Then, the expansion model which
includes a representative plaque and the artery is presented. Finally, the objective functions
(ﬁgures of merit), representing radial strength of a stent and injury caused by the stenting
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models for studying expansion of stents.
As mentioned earlier, in order to perform a design optimization study on stents, it is
necessary to model the expansion of stents for three reasons – ﬁrst, to evaluate recoil, second,
to evaluate the mechanical stress-strain environment in the artery, and third, to obtain the
expanded geometry for evaluation of ﬂow and drug distribution. In the following sections the
methodology adopted in this thesis for these purposes is presented.
5.2 Methodology
Of the various balloon expansion methodologies listed in section 5.1 the one proposed by
Gervaso et. al. [19] is adopted in this study. While Gersavo et. al. presented the results only
for free expansion, results for both free expansion and expansion into a representative plaque
and artery model are presented in this chapter. The following sub-sections detail the steps
of the analysis procedure.
5.2.1 Geometry
5.2.1.1 Stent
The CYPHER stent is chosen for developing the expansion methodology. This is because the
CYPHER stent –
• was a widely used stent in clinical practice until its discontinuation in 2011 [35].
• is representative of most contemporary stent designs – circumferential rings connected
by ﬂex connector segments.
• has been studied in the past in various FEA studies.
• has easily available pressure-diameter relationship chart provided by the manufacturer
after in vitro testing.
Figure 5.1 shows an electron microscope picture [34] of the Bx VELOCITY stent. Two
important features of the CYPHER/Bx VELOCITY stent geometry can be easily located.
First, it contains 4 circumferential rings placed in the longitudinal direction, and second, the
circumferential rings are connected by ‘n’ shaped connectors/links [34, 135].
Figure 5.1: Electron microscope image of Bx VELOCITY stent76 Chapter 5. Balloon expansion of stents
The important characteristics of the stent geometry used in this chapter are obtained
from the ‘instructions for use’ manual provided by the manufacturer [135] and ‘the handbook
of coronary stents’ [34]. Table 5.1 lists these properties
Table 5.1: Geometric information for the CYPHER stent
Dimension Value Note
Target artery diameter 3.00 mm a range of diameters are available; 3.0 mm is
chosen for this study
Length 8.00 mm a range of lengths are available; 8.0 mm is cho-
sen for this study
No. of circumferential cells 6 for 2.25-3.00 mm diameter stents, the number
of rings is 6
Strut thickness (radial) 0.14 mm converted from inches to mm (0.0055 inch)
Strut width (circumferen-
tial)
0.13 mm converted from inches to mm (0.0052 inch)
With the help of these geometric parameters and visual insepction of the crimped state
geometry, a representative model of the CYPHER stent is generated in Rhinoceros 4.0. The
semi-crimped state internal diameter is chosen to be 1.22 mm. An image of the semi-crimped
state CAD model is shown in Figure 5.2.
Figure 5.2: CAD model of the CYPHER stent
5.2.1.2 Balloon
To construct the geometry for the balloon two important dimensions are needed – the nominal
diameter and the length. The nominal balloon diameter is chosen to be 2.85 mm, which was
obtained by De Beule et. al. [134] after extrapolating the balloon’s compliance chart (provided
by the manufacturer) to a zero stress state. The nominal length of the balloon is speciﬁed
to be 10.0 mm according to the data in [135] which speciﬁes that the stent delivery balloon’s
length is nominally 2.0 mm longer than the stent being used. Based on this data the nominal
geometry of the balloon is created in Rhinoceros 4.0, see Figure 5.3.
Figure 5.3: CAD model of the nominal balloon5.3. Simulations 87
Figure 5.15: Loading proﬁle for the expansion of stent into the plaque and artery
Table 5.5: Diﬀerent mesh and time-steps used for veriﬁcation studies of stent expansion into
the plaque and artery
Name No. of elements No. of elements time-step
Plaque Artery (s)
PA Base 1e7 11948 19000 10−7
PA Base 1e8 11948 19000 10−8
PA Mesh1 1e7 25690 27072 10−7
PA Mesh1 1e8 25690 27072 10−8
PA Mesh2 1e7 40216 43200 10−7
PA Mesh2 1e8 40216 43200 10−8
stress results for PA Mesh1 and PA Mesh2 is less than 5%. Even though both PA Mesh1 and
PA Mesh2 are appropriate for stress calculations, PA Mesh2 is chosen for future optimiza-
tion studies, as it gives a better resolution of plaque geometry for subsequent CFD studies
(presented in chapter 8).
5.3.4 Choice of time-step for optimisation studies
Since design optimization is a process which needs evaluation of multiple points in a given
design space, multiple computational simulations are often not aﬀordable for complex anal-
yses. The expansion analysis presented in Section 5.3.2 suggests the use of a time-step of
10−8 seconds, in order to capture the numerical transient expansion which is dependent of the
time-step chosen. However, a close look at Figure 5.12 shows that the expansion behavior for
a time-step of 10−8 s is similar to that for a time-step of 10−7 s for pressures higher than 0.6
MPa with minimal errors. Based on this observation it is hypothesized that a time-step of
10−7 seconds can be used for optimization studies, as it reduces the physical simulation time
from about over a week to 24 hrs. To prove this hypothesis the following four arguments are
considered –
Figure 5.16: Line on the plaque inner surface on which the Von Mises stresses are compared92 Chapter 5. Balloon expansion of stents
Figure 5.22: Von Mises stresses (MPa) and maximum principal plastic strains on the stent
after free-expansion
Figure 5.23: Stages of transient expansion of the stent into the plaque and artery
Figure 5.24: Von Mises stresses (MPa) on the stent5.5. Results 93
Figure 5.25: Von Mises stresses (MPa) on the plaque
Figure 5.26: Von Mises stresses (MPa) on the artery
Figure 5.27: Average stent diameter for expansion into the plaque and the artery
Figure 5.28: Max. Principal plastic strains on the stent after expansion into the lesion94 Chapter 5. Balloon expansion of stents
stent, plaque, and the artery after the unloading phase. Figure 5.27 shows a plot of the
average diameter of the stent against the pressure applied, and ﬁgure 5.28 shows the max.
principal plastic strains for the stent at the end of the analysis (i.e. after the unloading
phase).
5.6 Discussion
For both the free-expansion and expansion into the lesion, the maximum stresses for the stent
are located at the curved parts of the struts (cf. ﬁgures 5.22 and 5.24). The maximum plastic
strains are also located in the same regions (cf. ﬁgures 5.22 and 5.28). Since the simulation
does not take into account the failure of the stent material, it is imperative to check that
the maximum total strain does not exceed the failure strain [10]. The plastic strains are
a key component in designing a stent. A good stent should, on one hand, undergo plastic
deformation at the right locations so as to maintain the shape, which would lead to minimal
recoil, while on the other hand the plastic deformations should not be large enough so as to
cause failure. In the representative CYPHER stent considered in this chapter, the equivalent
plastic strains are approximately 15%. The strut thickness (see Table 5.1) is 140 microns,
and from Figure 5.6 it can be seen for this range of strut thickness, the maximum permissible
strains are greater than 30%. Hence, it can be safely said that the representative CYPHER
stent would not fail for the expansion diameters used in this study.
For metallic stents, this constraint of not exceeding the maximum allowed plastic strains
and the observation that most stents have circumferential rings of varying shapes leads to
the conclusion that circumferential rings represent a vital component of a metallic stent.
This is primarily because very large plastic deformations for metals are not feasible, and it
seems that the circumferential rings provide a very eﬀective way for the expansion as well as
the retention of the expanded shape through plastic deformations. Other ways of expansion
usually employ the use of polymeric material properties. The patent by Johnson & Johnson
[151] presents very interesting ways for stent expansion by utilizing the material properties
of more plastic materials.
Looking at the stresses and strains at the links between the circumferential rings, they
seem to not be playing an important part in the expansion of the stent, apart from tying the
circumferential rings together. Nonetheless, the links play an important part in determining
the ﬂexibility of the stent, and their role is investigated in chapter 6.
Figure 5.25 shows that the stent leaves a heavy imprint in the plaque, causing the stresses
to be highest at the contact interface. Moreover, since the stent has to work most in the central
region, where the stenosis is highest, the stresses in the central plaque region are the highest.
The stent imprint can also be seen in the artery surface in ﬁgure 5.26. Observing all these
stress patterns in the plaque and the artery it can be concluded that the stress distribution in
these tissues is a function of the stent geometry. A good stent would ideally try to distribute
the stresses more uniformly, and minimize the maximum stresses. As mentioned earlier that
the quantiﬁcation of stresses is one way of quantifying injury caused to the tissue, a strategy
to quantify this numerical information is needed. This forms the content of the next section.Chapter 6
Flexibility of stents
The deployment of a stent involves the delivery system (comprising the balloon catheter and
the stent) to be manoeuvred through highly curved anatomical pathways to the stenosis site
[129]. Consequently, the ﬂexibility of the stent becomes a concern, as potentially rigid stents
give rise to various problems during deployment. The aims of this chapter are as follows
1. to develop a FEA model to model bending of an unexpanded coronary stent, and
2. to formulate an objective function which can be used to compare stents based on their
ﬂexibility.
This chapter starts with a review of methods that have been proposed to evaluate the
ﬂexibility of a stent. Thereafter an FEA model to simulate bending of stents is presented.
Finally, a ﬁgure of merit, which can rank stents based on their ﬂexibility, and hence in part
deliverability, is proposed.
6.1 Introduction
Although there are no standard tests to evaluate ﬂexibility of a stent, several methods have
been used in the past. These methods can be broadly classiﬁed as either experimental or nu-
merical. In the experimental regime either a one-point [157], three-point [158], or a four-point
[157, 159] bending test is generally used. In the numerical methodology, bending is either
measured by specifying the rotational displacements of the longitudinal ends and measuring
the moments required [141], or by applying the moments at the longitudinal ends and mea-
suring the rotational displacements [160]. Ormiston et. al. [158] compared 13 stent designs
(two coil, two hybrid, and nine slotted tube designs) both before and after stent expansion by
using a three-point bending test. They reported a strong correlation between expanded stent
stiﬀness and number of longitudinal strut interconnections, and a poor correlation between
expanded stent stiﬀness and strut-thickness. They also reported that expanded stents were
more stiﬀ than their crimped state counterparts. Szaba´ dts et. al. [157] compared six designs
by using one-point and four-point bending tests. Mori et. al. [159] also used four-point bend-
ing tests on four diﬀerent designs and proposed a simpliﬁed 2-D FEA method to evaluate
the eﬀect of stent parameters on ﬂexibility. Petrini et. al. [141] compared the ﬂexibility of
the Bx VELOCITY stent and the Carbostent (Sorin Biomedica, Saluggia, VC, Italy) using
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FEA. They proposed specifying the rotational displacements of the longitudinal ends to sim-
ulate bending, and then measuring the corresponding moments. They also showed that the
response of one unit of stent closely followed the response of the full stent, and suggested that
one unit of stent, being computationally cheaper, is ideal for ﬂexibility measurement. Wu et.
al. [160] proposed the use of multipoint constraints (MPC) in FEA to simulate the four-point
bending tests. Their proposed method, where the analysis is driven by application of mo-
ments, can be applied to achieve more complex bending shapes (such as an ‘S’ shape, which
is hard to simulate by specifying rotations) apart from the widely used pure-bending shape.
They reported that ﬂexibility of stents after they undergo plastic deformation is roughly 16
times larger than when they deform elastically only, and hence concluded that stents which
can be plastically deformed easily are more ﬂexible. Ju et. al. [161] proposed a repeated
unit cell (RUC) approach to simulate pure bending of coronary stents, and reported that the
geometry of the link was a key determinant of stent ﬂexibility.
In this chapter the methodology suggested by Wu et. al. [160] is used to simulate bending.
Thereafter, ﬂexibility, both in the elastic and plastic regimes, is quantiﬁed to be used in
optimization studies. The following sections discuss the approach used for this purpose.
6.2 Methodology
6.2.1 Geometry and material
Following the work by Petrini et. al. [141], which showed that the results of one unit of
stent are very similar to that of a full length stent, only a unit model of stent is used for
ﬂexibility analysis in order to save computational time. The parameters of the stent geometry
are the same as described in section 5.2.1.1, except that from the full length model, one unit
is extracted. Figure 6.1 shows this model. The material of stent used in this chapter is the
same as described in section 5.2.2.1.
Figure 6.1: A unit model of the stent
It must be noted that due to the plastic deformations in the stent during delivery, the stress-
strain history of the stent material for the expansion analysis will change. Consequently,
kinematic hardening eﬀects such as the Bauschinger eﬀect, will come to play during the
expansion of stent depending on the kind of plastic deformation occurred during the delivery
of the stent. However, as will be seen in this chapter, and in chapters 7 and 9, the plastic
deformation in the stent links is primarily important for delivery, and the plastic deformation
in the circumferential rings is primarily important for the expansion of the stent. In this
sense, for the stent designs considered in this thesis, these plastic deformations, and hence134 Chapter 7. Constrained optimisation of coronary stents
drugs is fully understood, the minimum and maximum levels of drug that are allowed to
be administered, depending on the toxic-to-therapeutic ratio of a particular drug, could be
ascertained. These values could then be represented in the constrained optimisation problem
as two constraints: one for the minimum therapeutic level and one for the maximum toxic
level. On the other hand, when such thresholds are not known, but it is known, for example,
that lower recoil, higher ﬂexibility, lower injury, and higher drug, are preferred, then a multi-
objective formulation of the design problem is more suitable. This is primarily because, such
a formulation, focuses on minimising all objectives simultaneously, rather than focusing on
only one objective at a time. Hence, a family of optimal designs, when all objectives are con-
sidered simultaneously, can be obtained using such a formulation. Such a formulation, which
also results in a better understanding of the trade-oﬀs involved in improving one objective
with respect to others, forms the content of chapter 9.8.1. Part I : Haemodynamics results 137
Figure 8.2: Volume mesh of the imported geometry
Figure 8.3: Volume mesh of the imported geometry: closeup
Figure 8.4: Axial WSS at point 5 of the cardiac pulse (c.f. ﬁgure 4.4)138 Chapter 8. Drug distribution in stented vessels
(a) Velocity proﬁle: links
(b) Velocity proﬁle: central region
Figure 8.5: Velocity proﬁles for ﬂow on geometry obtained post FEA analysis: point 3 (c.f.
ﬁgure 4.4) of cardiac pulse
Figure 8.6: Secondary recirculation8.1. Part I : Haemodynamics results 139
Figure 8.7: Tissue prolapse and it eﬀect on recirculation
Figure 8.8: Percentage area exposed to WSS magnitude below 0.5 Pa over the entire cardiac
pulse
Figure 8.9: Percentage area exposed to reverse ﬂow over the entire cardiac pulse140 Chapter 8. Drug distribution in stented vessels
8.2 Part II : Drug-distribution
In this section a CFD model to evaluate the distribution of drug in a stented artery segment
is discussed.
8.3 Introduction
The modelling of drug diﬀusion in the stented vessel applies to drug eluting stents which
release a drug to inhibit inﬂammatory response and smooth muscle cell migration and prolif-
eration. Since most drugs do not bind to the metallic stent surface easily, a polymer coating
is often needed both to ﬁx the drug on the stent and control the release kinetics [174]. Al-
though a uniform surface coating is the norm in DES, another technology known as the
reservoir (RES) technology is being researched by Conor Medsystems LLC, Johnson & John-
son. RES technology stents have small multiple reservoirs on the stent struts, each reservoir
comprising various layers of drug and polymers to control drug release [175, 176]. The drug,
a biologically active agent, arrests any one of the phases of the cell cycle. Figure 8.10 shows
this cell cycle [12], the series of events after stenting which lead to in-stent restenosis, and
the main targets of common drugs to inhibit restenosis. The cell cycle has four phases –
1. G1 phase – This is also known as the gap-1 phase (gap referring to the time between
the previous M phase and the beginning of DNA synthesis). During this phase various
enzymes are synthesized to be used for the S phase.
2. S phase – This phase involves DNA synthesis and replication of the chromosomes.
3. G2 phase – Also known as the gap-2 phase, this phase involves preparation (biosynthe-
sis) for the M phase.
4. M phase – This phase involves Mitosis which leads to separation of chromosomes and
cytoplasm.
Diﬀerent drugs attack the cell cycle at diﬀerent points, and consequently have a diﬀerent
mechanism of suppressing restenosis. The two most common drugs used in DES today are
Sirolimus and Paclitaxel. While Paclitaxel attacks the M-phase, Sirolimus inhibits the G1
phase. The implication of using diﬀerent drug types to arrest restenosis is out of the scope of
this thesis. Focusing on the engineering evaluation of drug-distribution, a general methodol-
ogy for drug transport, the diﬀusivity values of the drug depending on the type of drug used,
is presented here.
In the past many studies have been performed on the modelling of drug diﬀusion in
stented vessels. Hwang et. al. [177] performed experimental drug distribution studies by
spray-coating Palmaz-Schatz Crown stents with ﬂuorescein sodium ethlylene vinyl acetate
copolymer solution in dicholoromethane, and implanting these stents in bovine carotid ar-
teries. The resulting ﬂuorescence microscope images revealed a high spatial heterogeneity in
drug concentrations. They also evaluated the eﬀect of strut placement in the circumferential
direction by setting up a 2-D model and randomly placing the struts. They reported that
inhomogeneous stent strut placement along the circumference can result in a highly non-
uniform spatial distribution of drug in the tissue (implying higher concentration near struts
and a lower concentration in the inter-strut spaces). Lovich et. al. [178] performed perfusion8.3. Introduction 141
Figure 8.10: The cell cycle and targets for drugs used in DES [12]
experiments on calf carotid arteries and concluded that convective drug transport in the tis-
sue played a signiﬁcant role in de-endothelialised arteries when compared to those where the
endothelium was intact. Hose et. al. [170] studied Paclitaxel distribution from a BiodivYsio
stent using a computational model. They reported signiﬁcant heterogeneity in spatial distri-
bution of the drug in the tissue and attributed this to the design of the stent. Sakharov et.
al. [179] implemented reverse binding of the drug in the tissue and numerically showed that
high polymer diﬀusion resistance increased average concentration of the drug in the tissue.
Pontrelli et. al. [180] presented analytical solutions for the problem of 1-D drug transport
from a polymer layer into the tissue. Zunino [181] modelled the drug-release dynamics from
the stent coating in a 2-D setup and evaluated the eﬀect of drug properties, stent coating,
and arterial wall on drug dynamics. Borghi et. al. [182], in an axi-symmetric geometry,
evaluated the diﬀerence between pure diﬀusive transport and reverse binding. Balakrishnan
et. al. [183] implemented a coupled CFD and mass transfer model to study drug-release dy-
namics in a 2-D setup. They concluded that ﬂow alteration and location of struts were very
important to achieve higher drug deposition. Migliavacca et. al. [184] developed a model to
study drug-diﬀusion on a geometry obtained by FE stent expansion analysis. They proposed
a model for plasma inﬁltration into the tissue and then used the advection-diﬀusion equations
to model drug release. Their model accounted for reverse binding of the drug in the tissue and
the drug dissolved in plasma. Zunino et. al. [20] proposed a uniﬁed methodology to evaluate
the expansion, haemodynamics, and drug-release for DES. Their drug release simulations
involved a standard advection-diﬀusion process with no reverse binding of the drug with the
tissue. Feenstra et. al. proposed a sequential expansion and drug-release analysis. Along
with the geometry, they extracted the interstitial ﬂuid velocity, from the expansion analysis
and included reverse binding of the drug with the tissue. Similar to the work by Balakrishnan152 Chapter 9. Multiobjective optimisation study on the CYPHER stent
Figure 9.4: Flow chart detailing the optimisation methodology adopted in this chapter
Step 2: Construct Krigs for each objective using 15+5 points → perform an NSGA-II search
to obtain the Pareto front → identify ﬁve update points → analyse the new points.
Step 3: Construct Krigs for each objective using 15+5+5 points → perform an NSGA-
II search to obtain the Pareto front → identify ﬁve update points → analyse the new points
→ Stop.
Step 4: Appraise the optimal designs.
It is worth noting at this point that there are many methods proposed in the past to ﬁnd
update points. The method adopted in this chapter, i.e. to choose uniformly distributed
update points on the predicted Pareto front, is the simplest of these. For single objective
optimisation Jones et. al. [50] proposed an expected improvement criterion to ﬁnd update
points. This criterion was extended to multi-objective optimisation in many diﬀerent algo-
rithms [187, 188, 189, 190, 191, 192, 193]. A discussion on these algorithms is out of scope
of this thesis. Nonetheless, the choice of a full exploitive approach adopted in this chapter
is based on the following rationale: ﬁrst, it is observed from chapter 7 that the objective
functions modelled are not highly multimodal in nature, i.e. the physical responses show a
relatively simple trend of increase or decrease in terms of a particular parameter in the search
space modelled; and second the errors at the end of ﬁrst update (shown in ﬁgure 9.5) are

























Figure 9.18: Trade-oﬀ curves for all combinations of the six metrics: green front indicates Pareto front after ﬁst sample + ﬁrst update; blue front indicates
Pareto front after second update; and red front indicates Pareto front after the end of the third update9.5. Conclusions 177
adopted for choosing update points. However, on account of the extremely high evaluation
times needed for evaluation of all the objectives, a comparison of the performance of such
methods on the stent design problem is out of the scope of this thesis, and forms one area of
future work. Similarly, the results of this chapter show that not all pairs of objectives are in
conﬂict with each other. The apparent correlation between some objectives can be used to
decrease the number of objectives to less than six and consequently result in a more eﬃcient
optimisation study.
9.5 Conclusions
This chapter proposes a three-parameter technique to vary the design of the widely known
CYPHER stent. Six ﬁgures of merit (numeric indicators of a stent’s eﬃcacy) viz. acute recoil,
volume average stress, ﬂow index, volume average drug, drug uniformity, and ﬂexibility, are
formulated. A surrogate modelling technique coupled with NSGA-II is employed to obtain
the Pareto front showing the trade-oﬀ between diﬀerent sets of the six ﬁgures of merit. The
eﬀect of the three parameters on these metrics is also studied. It is demonstrated that a
change in one parameter that leads to an improvement in one of the objectives often leads
to a compromise in one or more of the other objectives. It is found that while strut width
and the length of the circumferential rings most aﬀect volume average stress and recoil,
the length of the links in the cross-ﬂow direction signiﬁcantly aﬀects volume average drug,
ﬂexibility, and the ﬂow index. The complex interplay between stent design (distribution of
struts, link design, strut thickness, and circumferential ring design) and stent performance,
from the perspective of the various conﬂicting/desirable properties, is clearly shown. Despite
this complex interplay, the non-dominated solutions, which represent a potentially optimum
family of CYPHER like stents, for the proposed parameterisation are obtained and discussed.
Moreover, several approaches for selecting optimal designs are identiﬁed and a parallel has
been shown between the constraint optimisation study presented in chapter 7. In particular,
designs 20 and 30 are identiﬁed as optimal in terms of all the objectives in a conservative
paradigm, and their relative position with respect to a representative CYPHER stent is shown.
Finally, in a constraint based approach, designs 15, 21, and 26 are identiﬁed as designs showing
maximal improvement, from the baseline geometry, in the corresponding chosen objectives.
In essence, a methodology to perform design optimisation studies on stents and the process
of choosing diﬀerent stent designs appropriate to diﬀerent needs is presented.
This chapter culminates the process of ﬁnding an optimal family of coronary stent de-
signs, by combining all the stent analysis methods developed in previous chapters in a single
multiobjective design study. The next chapter is not speciﬁc to the problem of coronary stent
design. It looks at Kriging-assisted optimisation at a more fundamental level, and explores
how derivative information in a Krig can be used for eﬃcient search of the Krig. This under-
lying idea emerged during the process of learning and applying the Gaussian Process models
as described so far.Chapter 10
An Optimisation algorithm that
exploits derivative information in
Kriging
In this chapter, the use of derivative information in a Kriging predictor, which is available
analytically, but not hitherto used in any known optimisation method, is explored to propose
an optimisation algorithm that can be used for both global and multimodal optimisation of
Kriging predictors. This chapter has stemmed from the process of learning and applying
Gaussian process models for the problem of stent design, and the ﬁrst principles belief that if
the analytical form for a function is available and diﬀerentiable, then it makes sense to equate
the analytical expression of the derivative to zero, and explore if any useful information can
be obtained from such an expression.
10.1 Motivation
The motivation for this chapter stems from the realisation that Kriging predictors can be
diﬀerentiated, and the fact that, to the best of author’s knowledge, this gradient information
has not been explored to be used in optimisation algorithms. Moreover, the exciting aspect
of using derivative information of a Krig is that no matter what underlying phenomenon is
being modelled by the Kriging predictor, the mathematical form of the Kriging predictor
remains the same. Hence, if an algorithm were to use this mathematical form to calculate the
derivatives, the need to code diﬀerent derivatives for diﬀerent functions is eliminated. Lastly,
the derivative information, if derived analytically, is available in exact form and need not be
approximated by ﬁnite diﬀerencing methods.
Based on these motivations, in this chapter the following tasks are performed:
1. An expression for the derivative of a Kriging predictor is derived.
2. The above expression is manipulated to yield a ﬁxed-point iterative sequence in order
to ﬁnd the stationary points of the Kriging predictor.
3. The convergence of such a ﬁxed-point iterative sequence is explored.
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Figure 10.1: Contours of the original Branin Function
Figure 10.2: Contours of the Kriging predictor (generated from sampling 20 points shown in
as red ’+’) for the Branin Function
Figure 10.3: Equation 10.40 applied to the Kriging predictor of Branin Function starting
from ﬁve diﬀerent points10.7. Comparison of the KNRS algorithm with other algorithms for Global optimisation 211
Figure 10.20: KNRS algorithm10.7. Comparison of the KNRS algorithm with other algorithms for Global optimisation 213
Figure 10.21: Best point average over 10 runs for ﬁve functions by the developers of DHC [13]:
(A) Sphere function, (B) Rosenbrock’s function, (C) Step function, (D) Quartic function, and
(E) Shekel’s function [13]
Step function; and ≈ 1,000 for the Shekel’s function.214 Chapter 10. An Optimisation algorithm that exploits derivative information in Kriging
(a) Sphere function (b) Rosenbrock’s function
(c) Step function (d) Quartic function
(e) Shekel’s function
Figure 10.22: Best point average over 10 runs for ﬁve functions to validate the DHC code
(Author’s code)10.7. Comparison of the KNRS algorithm with other algorithms for Global optimisation 215
10.7.3 Comparison results and discussion
To compare the performance of KNRS against the performance of GA and DHC, 50 runs of
all the three algorithms are performed for the 10 test functions in table 10.2.
Figures 10.23 – 10.32 show the optimisation histories for the best point and the mean of
the best point for 50 runs of the KNRS, GA, and DHC algorithms on the 10 test functions.
Table 10.5 shows the corresponding times taken for the 50 runs, and time per evaluation.
Before any comments on these numbers, the working of the KNRS algorithm is explored. Let
us consider Figure 10.23a. One observation is that since each NR iteration converges to one
of the stationary points of a function, the best point values in any run are likely to be the
stationary point function values for a long time, i.e. until any better point is found. This
leads to a band formation around the function values of the stationary points. In other words,
depending on the convergence accuracy of the inner NR iterations, the converged values of the
NR iterations lie in a small interval around the stationary points function values. For example
for the Branin function, the function value around the stationary points is approximately 20
and hence a a dark line (i.e. a set of lines corresponding to this band) is observed in Figure
10.23a. To further understand the working of this algorithm two independent runs on the
Branin function and key points along the run are shown in Table 10.4. Comparing the
ﬁrst run in Table 10.4 to Figure 10.23a, it can be seen that this is the only run on Figure
10.23a that has not converged to any of the minima of Branin function Krig. The most
likely reason for the non-convergence of this run is that a NR sequence is actually diverging.
This is an important issue, especially when a ﬁxed number of evaluations are allowed in the
algorithm. In the case of the Branin function, this limit is 50 evaluations. Now, if the number
of iterations in an NR sequence (without convergence) before which it is declared that the
sequence is either oscillating or diverging, is greater than 50, then if the ﬁrst point of the
SOBOL sequence starts to diverge, then there will be no function improvement in the entire
run. This issue can be resolved by either checking inside each iteration as to whether the
series is diverging or oscillating, or by keeping a sensible limit on the maximum iterations
for the NR sequence. In all the comparisons presented in this section, the latter approach is
adopted and the limit on maximum iterations in an NR sequence is set to 50. The eﬀect of
the diverging solution in the case of Branin function is also reﬂected in the plot for the mean
of the best point (Figure 10.23b): the dashed line represents the mean of all the 50 runs and
the solid line shows the mean when the run with the diverging solution is removed. This is a
direct result of choosing 50 as the inner iteration limit, and the fact that only 50 evaluations
are considered in these runs, thereby disallowing any further point to be evaluated before the
maximum evaluation limit is reached.
Returning to the comparison of the three algorithms on the 10 test functions (Figures
10.23 – 10.32), it is important to compare the time taken by each algorithm per evaluation.
Each algorithm has a diﬀerent mechanism to converge to the optima, based on what the
algorithm does after evaluating a point. It should be noted that the time per evaluation here
implies, the time taken by one complete inner iteration of an algorithm, i.e. time taken to
evaluate the function value once plus other inner workings of the algorithm. For example,
time per evaluation for KNRS includes time taken for generation of the next point in the
SOBOL sequence plus one iteration of the NR sequence and convergence checks within the
iteration. For the GA, time per evaluation is the time taken for selection, crossover, and
mutation, per generation divided by the number of members in a generation. Similarly, for10.7. Comparison of the KNRS algorithm with other algorithms for Global optimisation 219
For the Dropwave function, the performance of KNRS and DHC are comparable. Similar
to the Six-hump camel back function, the basin of attraction of the global minima for the
Dropwave is small relative to the search domain (see Figure 10.14d). DHC struggles equally
for this function due to the presence of concentric ridges which can cause DHC to oscillate
between these ridges.
10.7.3.3 Rastrigin’s & Ackley’s function
The Rastrigin’s and Ackley’s functions are the most multimodal among the test functions
used here. They both have regularly alternating minima and maxima, and saddle points
between them (Figures 10.9b and 10.11b). At ﬁrst glance, comparing Figure 10.26b with
Figure 10.26f, and more importantly Figure 10.28b with Figure 10.28f, it may be concluded
that the KNRS algorithm has performed extremely poorly when compared to DHC on these
functions. This is indeed true, when the goal is to ﬁnd the global optimum. However, further
insight is obtained by considering that facts that (i) a limited number of evaluations of the
algorithm have been performed for both the algorithms and (ii) the non-convergence of the
mean to the global minimum for the KNRS algorithm on these two functions is neither
because any of the starting points in the NR sequence are diverging, nor because the SOBOL
sequence is performing insuﬃcient exploration of the design space. Every NR iteration is
actually converging to the closest stationary point. Indeed, it is the sheer number of such
stationary points for these functions that 500 evaluations are not enough to gather entire
information about the landscape, i.e. the location of all stationary points including the global
minimum. This aspect, although magniﬁed for the case of Rastrigin’s and Ackley’s functions,
is relevant to all the functions. However, in other functions, the number of evaluations used
was suﬃcient to explore the search region suﬃcient enough to ﬁnd the global minima. This
aspect is demonstrated in Figure 10.34 where the results of one random run of the 50 runs
for all the test functions are plotted. The red dots show the locations where the various NR
sequences converged during this single run. Notice how many stationary points are found and
some are missed during each of these runs. Particularly notice the plots for Rastrigin’s and
Ackley’s functions. Here, inevitably, a few stationary points are missed if only 500 evaluations
are used. For some runs, these missed stationary points could as well be the global minima.
However, if the algorithm is allowed to run for a higher number of evaluations, the global
minima is to be found, inevitably, due to the space-ﬁlling nature of the SOBOL sequence.
Encouragingly, every NR sequence of the KNRS algorithm, unless diverging (which is
not the case for the Rastrigin’s and Ackley’s function), results in yielding some information
about the landscape of the function. Hence, it is the author’s hypothesis that the merit of
the KNRS algorithm, although eﬀective in a global optimisation problem, lies in multimodal
optimisation, where the goal is not just to ﬁnd the global minima but other optima as well
irrespective of their relative function values. This aspect is explored further in section 10.8.
10.7.4 Easom’s function
As mentioned earlier Easom’s function is an extremely challenging function for optimisation
algorithms because: a) the size of the basin of attraction of the global minimum is very small
when compared to the search domain; and b) the function elsewhere is relatively ﬂat, with a
function value close to zero. In Figures 10.31a and 10.31b, 23 out of 50 runs have not found220 Chapter 10. An Optimisation algorithm that exploits derivative information in Kriging
(a) Optimisation history KNRS : best point for 50 runs(b) Optimisation history KNRS: mean of the best point
for 50 runs
(c) Optimisation history GA : best point for 50 runs (d) Optimisation history GA: mean of the best point for
50 runs
(e) Optimisation history DHC : best point for 50 runs (f) Optimisation history DHC: mean of the best point for
50 runs
Figure 10.23: KNRS, GA, and DHC, algorithms on the Branin function: optimisation history
for best point and mean of the best point for sample of 50 runs
the global minima. One of the reasons for the relatively better performance of DHC for this
function could be the outer loop of DHC. In order to seed the inner loop, 50 random points
are evaluated and the inner loop is seeded with the best point among these 50 points. Clearly,
if any of these points lies in the basin of the global minima, DHC’s inner loop will quickly
converge to it. Nonetheless, if KNRS is allowed higher maximum evaluations, then the evenly
exploratory nature of the SOBOL sequence should ﬁnd the minima. This indeed happens, as
shown in Figure 10.33.
Lastly, as can be observed from Figures 10.23–10.32, a standard GA for the chosen test
functions, performs relatively poorly when compared to KNRS and DHC. In the next section
the multimodal optimisation capabilities of KNRS are explored in detail.10.7. Comparison of the KNRS algorithm with other algorithms for Global optimisation 221
(a) Optimisation history KNRS: best point for 50 runs (b) Optimisation history KNRS: mean of the best point
for 50 runs
(c) Optimisation history GA : best point for 50 runs (d) Optimisation history GA: mean of the best point for
50 runs
(e) Optimisation history DHC : best point for 50 runs (f) Optimisation history DHC: mean of the best point for
50 runs
Figure 10.24: KNRS, GA, and DHC, algorithms on the De Jong’s function: optimisation
history for best point and mean of the best point for sample of 50 runs222 Chapter 10. An Optimisation algorithm that exploits derivative information in Kriging
(a) Optimisation history KNRS: best point for 50 runs (b) Optimisation history KNRS : mean of the best point
for 50 runs
(c) Optimisation history GA : best point for 50 runs (d) Optimisation history GA: mean of the best point for
50 runs
(e) Optimisation history DHC : best point for 50 runs (f) Optimisation history DHC: mean of the best point for
50 runs
Figure 10.25: KNRS, GA, and DHC, algorithms on the Rosenbrock’s function: optimisation
history for best point and mean of the best point for sample of 50 runs10.7. Comparison of the KNRS algorithm with other algorithms for Global optimisation 223
(a) Optimisation history KNRS: best point for 50 runs (b) Optimisation history KNRS: mean of the best point
for 50 runs
(c) Optimisation history KNRS : best point for 50 runs(d) Optimisation history GA: mean of the best point for
50 runs
(e) Optimisation history DHC : best point for 50 runs (f) Optimisation history DHC: mean of the best point for
50 runs
Figure 10.26: KNRS, GA, and DHC, algorithms on the Rastrigin’s function: optimisation
history for best point and mean of the best point for sample of 50 runs224 Chapter 10. An Optimisation algorithm that exploits derivative information in Kriging
(a) Optimisation history KNRS: best point for 50 runs (b) Optimisation history KNRS: mean of the best point
for 50 runs
(c) Optimisation history KNRS : best point for 50 runs (d) Optimisation history GA: mean of the best point for
50 runs
(e) Optimisation history DHC : best point for 50 runs (f) Optimisation history DHC: mean of the best point for
50 runs
Figure 10.27: KNRS, GA, and DHC, algorithms on the Bump function: optimisation history
for best point and mean of the best point for sample of 50 runs10.7. Comparison of the KNRS algorithm with other algorithms for Global optimisation 225
(a) Optimisation history KNRS: best point for 50 runs (b) Optimisation history KNRS: mean of the best point
for 50 runs
(c) Optimisation history KNRS : best point for 50 runs(d) Optimisation history GA: mean of the best point for
50 runs
(e) Optimisation history DHC : best point for 50 runs (f) Optimisation history DHC: mean of the best point for
50 runs
Figure 10.28: KNRS, GA, and DHC, algorithms on the Ackley’s function: optimisation
history for best point and mean of the best point for sample of 50 runs226 Chapter 10. An Optimisation algorithm that exploits derivative information in Kriging
(a) Optimisation history KNRS: best point for 50 runs (b) Optimisation history KNRS: mean of the best point
for 50 runs
(c) Optimisation history KNRS : best point for 50 runs (d) Optimisation history GA: mean of the best point for
50 runs
(e) Optimisation history DHC : best point for 50 runs (f) Optimisation history DHC: mean of the best point for
50 runs
Figure 10.29: KNRS, GA, and DHC, algorithms on the Six-hump camel back function: op-
timisation history for best point and mean of the best point for sample of 50 runs10.7. Comparison of the KNRS algorithm with other algorithms for Global optimisation 227
(a) Optimisation history KNRS: best point for 50 runs (b) Optimisation history KNRS: mean of the best point
for 50 runs
(c) Optimisation history KNRS : best point for 50 runs(d) Optimisation history GA: mean of the best point for
50 runs
(e) Optimisation history DHC : best point for 50 runs (f) Optimisation history DHC: mean of the best point for
50 runs
Figure 10.30: KNRS, GA, and DHC, algorithms on the Dropwave function: optimisation
history for best point and mean of the best point for sample of 50 runs228 Chapter 10. An Optimisation algorithm that exploits derivative information in Kriging
(a) Optimisation history K: best point for 50 runs (b) Optimisation history KNRS: mean of the best point
for 50 runs
(c) Optimisation history GA : best point for 50 runs (d) Optimisation history GA: mean of the best point for
50 runs
(e) Optimisation history DHC : best point for 50 runs (f) Optimisation history DHC: mean of the best point for
50 runs
Figure 10.31: KNRS, GA, and DHC, algorithms on the Easom’s function: optimisation
history for best point and mean of the best point for sample of 50 runs10.7. Comparison of the KNRS algorithm with other algorithms for Global optimisation 229
(a) Optimisation history KNRS: best point for 50 runs (b) Optimisation history KNRS: mean of the best point
for 50 runs
(c) Optimisation history KNRS : best point for 50 runs(d) Optimisation history GA: mean of the best point for
50 runs
(e) Optimisation history DHC : best point for 50 runs (f) Optimisation history DHC: mean of the best point for
50 runs
Figure 10.32: KNRS, GA, and DHC, algorithms on the Goldstein-Price’s function: optimi-
sation history for best point and mean of the best point for sample of 50 runs230 Chapter 10. An Optimisation algorithm that exploits derivative information in Kriging
(a) Optimisation history KNRS: best point for 50 runs (b) Optimisation history KNRS: mean of the best point
for 50 runs
Figure 10.33: KNRS on the Easom’s function: higher maximum evaluations allowed10.7. Comparison of the KNRS algorithm with other algorithms for Global optimisation 231
(a) Branin function (b) De Jong’s function
(c) Rosenbrock’s function (d) Rastrigin’s function
(e) Bump function (f) Ackley’s function
(g) Six-hump camel back function (h) Dropwave function
(i) Easom’s function (j) Goldstein-Price’s function
Figure 10.34: Random KNRS run on the test functions: optimal solutions found in red circles10.9. Limitations 237
(a) Branin function (KNRS) (b) Branin function (DHC)
(c) Rosenbrock’s function (KNRS) (d) Rosenbrock’s function (DHC)
(e) Himmemblau’s function (KNRS) (f) Himmemblau’s function (DHC)
(g) Six-hump camel back function (KNRS) (h) Six-hump camel back function (DHC)
(i) Rastrigin’s function (KNRS) (j) Rastrigin’s function (DHC)
Figure 10.36: Performance of KNRS and DHC for ﬁve test functions238 Chapter 10. An Optimisation algorithm that exploits derivative information in Kriging
(a) Branin function (KNRS) (b) Branin function (GA)
(c) Rosenbrock’s function (KNRS) (d) Rosenbrock’s function (GA)
(e) Himmemblau’s function (KNRS) (f) Himmemblau’s function (GA)
(g) Six-hump camel back function (KNRS) (h) Six-hump camel back function (GA)
(i) Rastrigin’s function (KNRS) (j) Rastrigin’s function (GA)
Figure 10.37: Performance of KNRS and ﬁtness sharing GA for ﬁve test functions: results
at 200 generations of GA with a population of 100 members (except for Rastrigin where
population size is 200); and KNRS for 2500 evaluations of each function10.10. Note on SOBOL sampling in KNRS 239
tually ﬁnd all the optima; however this chapter has not addressed how eﬀective this process
might be as opposed to standard optimisation algorithms. Lastly, as observed in the case
for Bump function, in section 10.7.3.1, KNRS does not, in its current form, honour bounds.
Consequently, for constrained optimisation a modiﬁcation to KNRS is required.
10.10 Note on SOBOL sampling in KNRS
Even though the idea of global exploration through the use of a low-discrepancy sequence, such
as the SOBOL sequence, is developed independently by the author, there have been similar
use of low-discrepancy sequences for global optimisation in the past. These methods go by the
name of Single Linkage (SL) and Multi-Level Single Linkage (MLSL) algorithms. The reader
is referred to [221, 222, 223, 224, 225] for details of such algorithms. An important aspect of
these methods, which is also applicable to the KNRS algorithm, is that based on the number
of starting points for the local search, such as steepest descent (or NR sequence in KNRS),
and the number of local minima found, Bayesian estimates on the number of local minima in
the underlying function can be ascertained, see for example [221, 222, 223]. The evaluation
of such estimates, which can be used as a stopping criterion for the KNRS algorithm is out
of scope of this thesis, but forms an important part for future work. Similarly, theoretical
analyses such as those presented in [226, 227], can be used to obtain statistical evidence
that all the local minima of a function have been found. Lastly, it should be noted that
low-discrepancy sequences have also been used in evolutionary algorithms and evolutionary
strategies. The reader is referred to [228, 229] for details of these.
10.11 Conclusions
The following conclusions can be made from this chapter:
1. Starting with a realisation that Kriging predictors can be diﬀerentiated and that the
derivative information has hitherto not been explored, an expression for the derivative
of the Kriging predictor is derived. This expression is then manipulated to form a
ﬁxed-point iterative sequence to ﬁnd the stationary points of a Kriging predictor.
2. The ﬁxed point iterative sequence is evaluated for its convergence and its convergence is
explored on the Branin function. In order to overcome the limitations of the ﬁxed point
iteration, a modiﬁcation of the sequence is proposed. Moreover, a Newton-Raphson
equivalent of the same ﬁxed-point sequence is derived, which guarantees convergence
to stationary points provided the starting point is close enough to the stationary point
(within the basin of attraction).
3. The convergence of the MFP and NR sequences are further explored and tested on a
test suite of 10 two-dimensional functions.
4. Based on the performance of the Newton-Raphson sequence on the above test functions,
a new algorithm, called KNRS, is proposed.
5. The performance of KNRS is tested for global optimisation against a genetic algorithm
and a dynamic hill climbing algorithm for a test suite of 10 two-dimensional functions.240 Chapter 10. An Optimisation algorithm that exploits derivative information in Kriging
6. For global optimisation KNRS performs favourably relative to GA for all the test func-
tions, and favourably relative to DHC on most test functions. From the results it is
realised that an important merit of the KNRS algorithm lies in multimodal optimisa-
tion.
7. The performance of KNRS for multimodal optimisation is tested against a ﬁtness shar-
ing genetic algorithm and a dynamic hill climber.
8. On the test functions chosen, KNRS performs favourably relative to both a ﬁtness
sharing GA and DHC.
9. The capabilities of KNRS, both for global optimisation and multimodal optimisation,
have not been evaluated in higher (greater than two) dimensional spaces.Chapter 11
Conclusions & recommendations for
further work
11.1 Conclusions
The following subsections present the conclusions made from this thesis.
11.1.1 Most Signiﬁcant contributions
Even though the area of interventional cardiology has witnessed a rapid evolution in coronary
stent designs – from bare-metal stents to drug-eluting stents to biodegradable stents – there
exists a substantial gap between the engineering analysis of stents, their comparison based
on such analysis, and the use of such comparisons to design better stents by the use of
optimisation methods. To ﬁll this gap, the most signiﬁcant contributions made by this thesis,
to the ﬁeld of coronary stent design, analysis, and optimisation are:
1. the development of engineering models to evaluate a stent’s performance based on var-
ious features relevant to in-stent restenosis, and formulation of the corresponding stent
evaluation metrics,
2. demonstration of how design improvement can be obtained in both constrained and
multiobjective optimisation studies for the problem of stent design,
3. demonstration of how the parameters deﬁning stent geometry inﬂuence various physical
features that are directly related to in-stent restenosis, and
4. demonstration of various paradigms which determine the choice of an ideal stent, from
a set of stent designs, based on various needs.
11.1.2 Multiobjective study
A NURBS based three parameter parameterisation for the widely studied CYPHER stent,
Cordis corporation, Johnson & Johnson company, is proposed. Based on this parameter-
isation, a multiobjective optimisation study, using surrogate modelling and NSGA-II, is
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11.2 Recommendations for Further Work
Although a number of conclusions have been made regarding the inﬂuence of stent design
parameters on factors aﬀecting in-stent restenosis, a number of improvements can be made
in both stent analysis and stent optimisation. In the area of searching the GP models, KNRS
oﬀers a range of extensions for further investigation. The areas of further work can be broadly
classiﬁed into
1. Improvements in stent analysis
a) Realistic geometry of stenosed arteries;
b) Realistic morphology of stenosed arteries (layers, anisotropy);
c) Transient release of drug-distribution (including factors like reverse binding of
drug).
2. Improvements in stent optimisation methodology
a) Parameterisation techniques for stent design;
b) Reﬁnement of objective functions;
c) Reﬁnement in terms of surrogate update methods;
d) Treatment of the design problem as a many-objective problem.
3. Investigation and extension of KNRS
a) Investigation of performance in higher dimensional spaces;
b) Possibility of a surrogate update method by KNRS;
c) Extension to constrained optimisation;
d) Extension to multiobjective optimisation.
The following sections outline each of the above themes.
11.3 Improvements in stent analysis
Further work in this area is primarily needed to make the stent analyses more realistic. In
particular, eﬀorts in the following areas are required
11.3.1 Realistic geometry of stenosed arteries
Throughout this thesis, a representative model for the geometry of stenosed artery is used.
The artery is assumed to be cylindrical and the plaque is deﬁned by the Hicks Henne bump
function. In reality, the geometries of stenosed arteries can be very complex with high cur-
vature and asymmetric distribution of plaque. An inclusion of such geometries, which can
be obtained by intravascular ultrasound and magnetic resonance imaging techniques, in the
analyses models – for both balloon-expansion and haemodynamic alteration – will further
enhance the understanding of the interaction between the stent and the artery.11.5. Investigation and extension of KNRS 247
• A mesh morphing technique can be implemented to directly manipulate the mesh, rather
than the curves/surfaces deﬁning the stent geometry. This is particularly attractive as
automated meshing of complex geometries is currently quite hard.
• Intellectually most challenging, inspiration from nature such as the bifurcation patterns
of the arteries, patterns of vein bifurcation in leaves, can be used to create stent pa-
rameterisation techniques. These, by virtue of natural evolution are optimised at least
for one objective (for example, the vein bifurcation patterns of leaves is optimised for
nutrient transport which can be seen as analogous to drug-delivery).
11.4.2 Reﬁnement of objective functions
In this thesis several objective functions which relate measurable quantities from engineering
analyses to the factors that contribute towards in-stent restenosis are formulated. As a ﬁrst
approximation, average measures for stress and drug delivered are introduced. However, it
is not yet clinically known whether it is the peak stresses in the artery, irrespective of the
location where such peak stresses occur, or it is the volume average measures that the human
body responds to in terms of restenosis. Similarly, for drug-delivery, perhaps only the volumes
of tissue which receive less drug than a certain therapeutic threshold, and not the average
amount of drug delivered, are relevant in terms of restenosis. Further investigation, more
from the clinical community, is needed in such regards.
11.4.3 Reﬁnement in terms of surrogate update methods
It was discussed in chapter 9 that many methods to decide update points for multi-objective
kriging assisted optimisation have been proposed [187, 188, 189, 190, 191, 192, 193]. The
choice of these update methods, as opposed to the simple pure exploitative approach adopted
in this chapter, could lead to an improved set of non-dominated solutions. Further investi-
gation, regarding the performance of such algorithms for the problem of stent design will be
very useful.
11.4.4 Treatment of the design problem as a many-objective problem
This results of this thesis have shown that many objective pairs in the optimisation problem
deﬁned in chapter 9 are correlated to each other, rather than being in conﬂict. Methods from
the ﬁeld of many-objective optimisation methods, can be employed to reduce the number
of objectives to fewer than six to decrease the complexity of the problem. This will both
minimise the time required for high-ﬁdelity simulations and with fewer objectives will lead to
better estimation of the Pareto front.
11.5 Investigation and extension of KNRS
In the development of KNRS, an intial algorithm is proposed in this thesis. However, further
investigation of the performance of this algorithm is needed in the following areas248 Chapter 11. Conclusions & recommendations for further work
11.5.1 Bayesian analysis for an estimate of the number of local minima
Using methods such as those presented in [221, 222, 223], an analysis which determines a
Bayesian estimate on the number of local minima of the underlying function, based on the
number of NR sequence starting points and the number of local minima found by such starting
points, needs to be performed in future. Such an analysis can lead to an eﬃcient stopping
criterion for the KNRS algorithm.
11.5.2 Investigation of performance in higher dimensional spaces
The 10 test functions that are chosen in this thesis are all complex but 2-dimensional. Conse-
quently, the relative performance of KNRS with other algorithms like GA, which are known
to have a better search power in higher dimensional spaces, for both global and multimodal
optimisation remains to be explored.
11.5.3 Possibility of a surrogate update method by KNRS
With the search performed by KNRS, one advantage is that all the stationary points of the
Krig are located. Perhaps, using this information about the landscape of the current form of
the Krig, an update methodology to balance exploration and exploitation can be developed.
The ideas for this are still at a nascent stage, for which further work is required.
11.5.4 Extension to constrained optimisation
The results of the performance of KNRS on the 10 test functions, in particular the Bump
function, showed that KNRS, in its current form, does not honour any constraints. Hence,
a modiﬁcation of KNRS to include both equality and inequality constraints is needed. En-
couragingly, since the form of equations used in KNRS is universal, i.e. it is related to the
Krig rather than the function itself and hence has the same mathematical form for every
function, methods from classical optimisaion (such as gradient projection methods) can be
used to formulate the constrained version of the algorithm.
11.5.5 Extension to multiobjective optimisation
Lastly, an extension of KNRS for multiobjective optimisation is needed. The author has
made signiﬁcant progress in this regard. This formulation and some preliminary results are
presented in appendix D. This extension to multiobjective optimisation, however, needs more
testing in higher dimensional objective spaces.Appendices
249256 Appendix B. Eﬀect of shear-thinning on results of chapter 4
Figure B.1: Wall shear stress magnitude on the central line of a representative NIR stent
(Stent-C in chapter 4): results for steady state ﬂow comparison with Newtonian and non-
Newtonian blood properties. The non-newtonian model adopted is the Carreu model [16];
steady state ﬂow velocity = 0.1382 m/s
Figure B.2: Wall shear stress magnitude color plot on a representative NIR stent (Stent-C
in chapter 4): results for steady state ﬂow comparison with Newtonian and non-Newtonian
blood properties. The non-newtonian model adopted is the Carreu model [16]; steady state
ﬂow velocity = 0.1382 m/s258 Appendix C. Results for baseline geometry for constrained optimisation study
expansion. As with the stresses it can be readily observed that the curved regions of the
circumferential rings are the regions where maximum plastic strains occur. These plastic
deformations restrict recoil of the stent. A geometry which allows more plastic deformation
in these areas has less acute recoil. It can also be observed from Fig. C.3 that the curved
regions of the links have relatively higher plastic strains than the straight segments of both
the circumferential rings and the links. When the circumferential rings expand their axial
length decreases, to account for the increased angle between the struts of the circumferential
rings. This causes an axial stretching of the links which leads to plastic deformation at the
curved tips of the links.
Figure C.1: Transient balloon expansion of the baseline geometry stent
Figure C.4 shows the results of the ﬂexibility analysis, in particular the deformed state
Figure C.2: Stent, plaque, and artery ﬁnal stresses, and average radius vs. time plot for the
baseline geometry260 Appendix C. Results for baseline geometry for constrained optimisation study
Figure C.5: Moment-curvature index curve for the baseline geometryReferences
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